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SUMMARY
The flux of metabolites within the cell is discussed.
Two approaches were used in the study of this subject:
(1) A preliminary investigation of the controlling factors
of adenine metabolism in red blood cells was undertaken.
(2) A study was made of adenylate cyclase in red blood cells
and of the cyclic-AMP binding proteins of the bovine adrenal
cortex.
AMP deaminase was partially purified from human and
sheep erythrocytes. This greatly facilitated the spectrophoto-
metric assay of the enzyme.~s activity. Some properties of
this enzyme were studied.
A method for examining the control of purine flux was
developed by the use of radioisotopic tracers. The possibility
of its use as a diagnostic ass~y for metabolic aisorders is
discussed. Adrenalin, which modifies the erythrocyte membrane,
was tested for any effect it might have on the rate of trans-
port of adenine into the red blood cell.
The adrenal in or fluoride ion stimulated activities of
adenylate cyclase were measured in turkey, rat and'human red
blood cells. The assay used was the saturation analysis
procedure of Brown et al. (1971) using a cyclic-AMP binding
protein f~om the bovine adrenal cortex. The cyclic-AMP binding
mOiety is the cyclic-AMP dependent protein kinase regulatory
subunit. The crude preparation used in the assay for cyclic-
AMP was fractionated by several methods and cyclic-AMP binding
studies were carried out on the different fractions.
Particular attention was paid to the interpretation of
binding data. It was found that under different conditions
certain preparations of the binding protein could produce
either linear or curved binding plots ('bound' against 'bound/
.,fr~e' 11gan4)." Tl,\ecauses of this are diecuesed. Theresul t
of the binding study has mechanistic implications
(xi)
INTiWDUCTION
1.A. The control of metabolic flux: general considerations
The control of enzyme activities and the resultant
metabolic fluxes is a topic that is receiving ~uch
attention now that the enzymes of the various metabolic
pathways have been studied in some detail. 'There are
many factors which contribute to the total control of
a metabolic pathway and figure 1.1 is an attempt to
summarise most of these. It may be helpful to look at
some of the different factors that effect control
under generalised headings.
Enzymes
(i) The synthesis and degradation of enzymes them-
selves is undoubtedly a controlled process-and may
affect the metabolic flux. However, even the enzymes
with the most rapid decay rates have half lives of a
few hours (Schimke: 1969).
(ii) The kinetics of the enzyme catalysed reaction
will depend on the substrate concentration and the
l.A.a ..
concentration of any coenzymes" inhibitors or activators.
Some enzymes have a sigmoidal response of activity
against substrate concentration. This may be due to
multisubstrate kinetics or some allosteric mechanism.
Whatever the source of the sigmoidal kinetics, though,
it has potential for control purposes~
(iii) The maximum activity of an enzyme (Vmax) is
an important consideration in understanding control.
In any pathway control is exerted at the rate limiting
step. In branched pathways there may be a number of
such steps. If, therefore, the Vmax is high an enzyme
has little potential for control purposes unless in
the cell it is strongly inhibited. Thus a knowledge
of the enzyme's kinetic constants (Vmax' ~) and
inhibitor constants (Ki) is important.
-1-
Figure 1.1
CONTROL OF E~ZYME ACTIVITY
and metabolic flux
STATE OF CELL AND ORGANISM AS A WHOLE
ENZYME ENZYME
SYNTHESIS BREAKDOVvN
~ OESTABILIZERS I
I INDUCERS ~ ENZYME .~POOL STABILIZERS I
I ACTIVATORS I Q) 0 I INHIBITORS I
OTHER RE AC TION~ ENZYME OTHER REACTIONS
OR ACTIVITY OR
COMPARTMENTS COMPARTMENTS~A:O~~ /
SUBSTRATE V . FLUX :,. PRODUCT
POOL . POOL
<, .>
TRANSPORT AND I OR DIFFUSION
'I
EXTRA-C ELLULAR 1_ __...
OTHER CELLS
POOL
OR ORGANS
<, <,
.~ SYNTHES IS ~. J BREAKDOWN, L.
/ <.
I NGES TION EXCRETION
1.A.b.
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Substrates
The concentration of the substrate will be a
coritrolling factor in the metabolic flux only if it
is non-saturating for the enzyme catalising the
reaction. It is also unlikely to be a controlling
factor if the enzyme catalised reaction is near
equilibri~~; that is, if the 'mass action ratio' of
product concentrations and substrate concentrations
is near the reaction equilibrium constant (rtolleston:
1972; see also section d). Determination of the mass
action ratio is not necessarily straightfo~vard.
Compartmentalisation of substrate ~~d/or product may
seriously obscure the true situation (l.D).
In some situations the diffusion or transport of
a substrate or product may affect the flux of a path-
way i f the enzymically catalysed reaction is near
equilibrium. Such may be the case for lactate dehydrogen-
ase in muscle. The diffusion of lactate into the blood
and its consequent removal may be a limiting factor in
the rate of the reaction (Newsholme and Start: 1973).
Cofactors can be considered under the general
heading of substrate. It is unusual and unexpected to
find control exerted by cofactor availability, although,
the ratio between the concentrations of ATP and A"JP,
for example, is thought to be important in the control
of phosphofructokinase activity. In general their wide-
spread usage and the specific nature of control
mechanisms are not compatible.
I.A.c. Inhibitors
Feedback inhibition is an important feature of
control mechanisms. A related control feature is feed-
fonvard activation. In each of these control mechanisms
a metabolically related compound exerts a control on
the pathway at a remote point. In the case of feedback
inhibition this is usually the first committed step
of a metabolic pathway.' However, in some cases an
inhibitor appears to bear no simple relationship to the
substrate or the pathway in which it is involved. The
-3-
I.A.d.
significance of such control is not immediately
apparent.
Energy of the reaction
(i) In all reactions energy is conserved. Bio-
chemical energy is conserved in the form of chemical
bonds. In a reaction at equilibrium the change in
free energy is zero, and there is no change in product
or substrate concentrations.
~ G == RTlnK + RT:''''([Products] )..u~[Substrates]
The mass action ratio of product and substrate
concentrations (strictly activities) is equal to the
equilibrium constant. All the energy is conserved in
chemical bonds but the net flux is zero. Biochemical
flux requires reactions to be displaced from equilbrium.
Reactions in which the mass action ratio is near the
equilibrium constant will be highly efficient.
(ii) In some reactions energy is released in the
form of work or dissipated as heat. This 'loss' of
energy (biochemical energy) results in a reaction that
is displaced from equilibrium towards the products. A
reaction in which this displacement is very large is
usually termed an irreversible reaction. It is these
non-equilibrium reactions that both require and produce
a constant exchange of material and are therefore
important sites for the control of flux.
I.A.e. Situation of the controlling enzymes
On the-basis of the previous discussion it can be
seen to be necessary that a controlling enzyme should
be rate limiting under the conditions in which its
control is exercised. It is also necessary for the
enzyme to be subject to inhibition or activation and
it is usual for it to catalyse a non-equilibrium reaction.
A consideration of the position of enzymes in a
pathway reveals probable sites for control albeit by
teleological reasoning. The initial steps in a path-
way are an obvious site for feedback inhibition.
Branch points and the following steps are important
points as are the final interconversions.
-4-
Substrate cycles (see fig. 1.2) can be a means of
amplifying a response to an effector. The two reactions
should be non-equilibrium reactions and subject to
opposite controls by a regulator.
Figure 1.2. R
cbV,
A~B~C~D~E-tF
~
R
A---F is a schematic representation of a metabolic
pathway in which the interconversions between C and
D are catalysed by two enzymes 1 and 2 with rates
VI and v2 respectively. If we stipulate that VI is
greater than v2 then the rate of substrate cycling
is v2 and the turnover rate is VI - v2• If e
regulator R activates 1 and inhibits 2 the the rate
of cycling is decreased and the rate of turnover is
increased by a larger amount then if it were subjed
to one controlling enzyme. (Newsholme and Start:
1973)
Another means of amplification may be termed 'enzyme
cycles'. Here an enzyme converts another inactive
enzyme into an active form or vice versa. An example
of this is the adenylation of Escherichiacoli glutamine
synthetase (see fig. 1.3) or the phosphorylation steps
involved in the activation of phosphorylase b (see
fig. 1.4). This latter form of amplification appears
to be a general feature ~ many hormonal actions
mediated through the activation of adenylate cyclase and
protein kinases (see section 1.G.).
I.B. Red blood cells
Erythrocytes were chosen as the tissue in which
to study some aspects of the control of purine metab-
olism because the cells are readily available and
uniform in nature. A separation on the basis of age
can be made if necessary and a considerable amount of
data has already been accumulated concerning the
enzymology of the cell and in particular the purine
pathways. Also the metabolism of purines in the red
Figure 1.3
Activation of E. coli
Gluta~ine Synthetase
12 ATP
M 2+.g
P. (or 24 P.)
J.. J..
Glutamine synthetase adenylating enzyme
Glutamine
synthetase
active
Glutamine
synthetase !-AMP12
inactive
Glutamine synthetase deadenylating enzyme
r
Gln iATP12 AMP
AMP -Ketoglutarate
The regulation of glutamine synthetase from E. coli
by enzyme catalysed chemical modification.
~ indicates a positive effector (stimulation)
~ indicates a negative effector (inhibition)
This figure is taken from Holzer (1969)
Figure 1.4
Activation of Phosphorylase-b
IPhOsPhodiesterase]
~ATP cyclic-~~ Ah~
Phosphorylase kinaseLL Phosphorylase kinas Cyclic-A1llP
kinase kinase regulatory
+(Protein kinase) (Protein kinase) subunit
(inactive) (active) complex
Hormone
+
n ATP +
Phosphorylase kinase
(inactive)
Phosphoprotein
phosphohydrolase
4 A'rp +
Phosphorylase-b
4 pyr
(inactive)
Phosphorylase
phosphatase
n ADP +
___ ~ Phosphorylase kinase-P
(active)
4 ADP +
Phosphorylase-a
4 pyr-P
(active)
The regulation of glycogen phosphorylase from
rabbit skeletal muscle by enzyme catalysed chemical
modification. This figure was taken from Holzer (1969).
It shows the 'enzyme cascade' by which the signal from
a hormone (e.g. adrenalin,) is amplified. Cyclic-AMP
also causes the phosphorylation of glycogen synthetase
which in the case of that enzyme inhibits it.
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cell is simplified by the omission of a number of
enzymes. The enzymio
shown in figure 1.5.
the human erythrocyt e
conversions in the pathway ~e
The steps which do not occur in
are indicated by dotted line~.
Mammalian red cells have no nuclei and therefore n~
DNA. RNA is rapidly degraded during and after the
reticulocyte stage of red cell development. The
absence of the de novo purine synthetic pathway an~
of the enzyme IMP:L-aspartate ligase (GDF) means tnat
erythrocytes rely on the supply of exogenous purin~s
and have a specific requirement for adenine (or
adenosine).
1.0. The enzymes of the purine pathway
Table 1.1 summarises much of the available
information regarding the enzymes of this pathway. A
study of most of these enzymes has been carried out
though not in all cases with h~an erythrocytes as
the source of th~ enzyme. Most attention has been
directed to the enzymes involved in the metabolism of
adenine and its derivatives.
1.0.a. Adenine phosphoribOsyl-transferase (AFRT)
APRT is a soluble enzyme that has been purified
2000 fold from human erythrocytes (Srivastava and
Beutler: 1971). They studied the basic enzyme kin'tics
and the effects of temperature, metal ions, organid
anions and sulphydryl reagents on the enzyme's
activity. They proposed that the reaction mechani'm
was ordered (see figure 1.6). This is in agreemen~
with the mechanism proposed by Henderson et al. (1~67).
Henderson also found that in 15% of a random sampl. of
people the APRT was unusually heat stable. This s~ggests
the possibility of there being isoenzymes of APliT. A
partial deficiency of the enzyme has also been recdrdea
(Henderson et al.: 1969) but there were no clinicat
manifestations of this. The actual role of the en~yme
appears to be one of salvaging adenine, though it ~ay
do so in the process of keeping the adenine concentration
below toxic levels.
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1.C.b. ATP:.AMP phosphotransferase (AMP kinase)
AMP kinase has been partially purified from human
erythrocytes and has been shown to exist as two
comnonly inherited isoenzymes. These isoenzymes differ
sli[~tly in heat stability, iodoacetamide inhibition
and kinetic parameters. The proposed mechanism for
their reaction is a random order rapid e~uilibrium
(Bro- .....nson and Spencer: 1972 a & b). This enzyme has been
found in both soluble and membrane bound cell fractions.
This may be related to the observation that ADP can
pass into the red. blood cell but cannot pass out of
the cell. M~P and ATP car~ot traverse the cell membrane
(Kashket and Denstedt: 1958). Rose (1968) has shovm
how the equilibrium constant of the reaction varies with
magnesium ion concentration.and pH.
1.C.c. Al£P aminonydrolase (AMP deaminase)
Human erythrocytic AkP deaminase has been studied
in crude haemolysate preparations. Rao et al. (1968)
have shown the enzyme to be partially associated with
the cell membrane. Askari (1963) showed that the enzyme
required ammonia or a monovalent metal ion for activity.
The activity was highest with potassium which is the
physiologically activating ion. ATP was shown ~o
enhance the metal ion activation (Askari and Franklin:
1965). The enzyme is strongly inhibited by 2,3-ai-
phosphoglycerate (2,3-DPG) at physiologically significant
concentrations. The response of activity to ~tiP
concentration is sigmoidal except in the presence of
sufficiently high concentrations of ATP (>2mM). The
effect of 2,3-DPG is to enhance thesigmoidicity of
thi~ response (Askari and Rao: 1968).
1.C.d. 51-Ribonucleotide phosphohydrolase (51-Nucleotidase)
51-Nucleotidase has not been studied from the
hWJan erythrocyte. There are numerous stUdies on the
enzyme from various sources: human liver (Song and
Bodansky: 1967); human aorta wall and placenta (Ahmed
and Reis: 1958); human tissue distribution (Reis:
1951); calf intestine (Center and Behal: 1966); sheep
brain (Ipata: 1967); Erhlich ascites tumour cells
(Murray and Friedricks: 1969); rat heart (Sullivan and
-7-
Alpers: 1971) and others.
1.C.e. ATP: adenosine 5'-phosphotransferase (Adenosine kinase)
Adenosine kinase from human erythrocytes was
studied as part of an investigation into the oetabolism
of adenosine by blood (l'Ieyskensand Nilliams: 1971).
The enzyne associated with erythrocyte ghosts has been
studied by Uustafa et al. (1972) particularly with
reference to the effect of detergents on the enzyme's
activity. It is inhibited by high concentrations of
ATP (>1.25nilll)though this may depend on the magnesium
concentration.
1.C.f. Adenosine aninohydrolase (Adenosine deaminase)
,Lrleyskensand Nillia.rnsalso studied adenosine
deaminase. Although this enzyme is associated with
the membrane (lliustafaet al.: 1972) it is not strongly
bound to it (Mitchell et al.: 1965). It is inhibited
by high concentrations of adenosine ( 10 x Km).
1.C.g. Purine-nucleoside: orthophosphate ribosyl transferase
(PNPlase)
The PNPlase of human erythrocytes has been
crystallised and extensively studied. It has a
molecular weight of 81,000 and a single active site
for the competing substrates (Kim et al.: 1968$. The
reaction ~echanism is considered to be an ordered bi-bi
mechanism. There is no apparent ribosylation of the
en~yme (Kim et al. 1968b). There has been controversy
over the question of whether adenine is a substrate of
the enzyme. Zimmerman et al. (1971) have demonstrated
that the crystalline enzyme is capable of catalysing
the conversion of adenine to adenosine at 0.0017 the
rate of hypoxanthine conversion to inosine. The
equilibrium constant for the reaction inosine to hypo-
xanthine is approximately 0.03.
Turner et al. (1971) have demonstrated seven
,electrophoretically different isoenzymes. The red cells
were separated on the basis of age by density gradient
centrifugation. The distribution of isoenzyoes
changed according to the age of the cell: from young
cells with slower moving bands to old cells with faster
(anodal) bands.
Figure 1.6
Reaction Mechanisms of Some Purine Enzymes
APRT ordered reaction
+PRPP +ade -Pp. -AMP
E E*PRPP *PRPP F*A.I.1P F*A2::.;p EE -*ade - *pp.
~
Henderson et al. (1969) ; Srivastava and Beutler (1971)(P. 5)
AMP kinase -- random order reaction
+AMP
E
+ATP.I':1g -ADP -ADP.l'ilg
,__--------..
E
+ATF .UIg +AlIiP -ADP.Mg -ADP
Brownson ~Dd Spencer (1972b)(p. 6)
PNPlase ---- bi-bi reaction
+ino +p.~ -R-l-P -hyp
E *.E ~no E*ino_ F*hyp*p. _ *R-l-Pa
E
Kim et al. (1968)a (p. 7)
HGPRT ----- ordered reaction (possibly with a phosphoribosyl-
enzyme intermediate)
-IMP
E
+PRPP
-PP.
*IMP ~ *PRPP
E (---------E-RP(--------E
P
-PP
]. *PRPP
E*hyp
Kelley et al. (1967~; Henderson et al. (1968); Krenitsky
and Papiaoannou (1969) (p. 8)
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1.C.h. Hypoxanthine-guanine phosphoribosyl transferase (HGPRT)
Since the discovery of the Lesch-Nyhan syndrome
(Nyhan: 1968) and its association with a deficiency of
HGPRT (Kelley: 1968) this enzyme has received much
attention. It is a single enzyme (M. Nt. 60,000)
catalysing the reactions between 5-phospho- ot,D-ribose-
I-pyrophosphate (PRPP) and the three purine bases
hypoxanthine, xanthine and guanine to give the respect-
ive nucleotides IMP, XMP·~~d G~~. HGPRT has an ordered
reaction mechanism involving a ternary complex (Kelley
et al.:1967aand Henderson et al.: 1968). The reaction
may involve the formation of a phosphoribosyl-enzyme
intermediate (Krenitsky and Papiaoannou: 1969). A
partial deficiency of the enzyme is one of the many
causes of gout (Kelley et al.: 1967b and Wyngaarden and
Kelley: 1972).
1.C.i. Less well studied purine enzymes
ATP: GMP phosphotransferase (GMP kinase) has been
isolated from human erythrocytes and been found to
exist as four isoenzymes (Agarwal and Parks: 1971 & 1972~
Bishop (1960) recorded an absence of xanthine: 02
oxidoreductase (xanthine oxidase) and guanine amino-
hydrolase (guanase) from human erythrocytes. He found
that C14_hypoxanthine was converted to Il~ arid to GTP
thus indicating the presence of active IMP: NAD+ oxido-
reductase (I1W dehydrogenase) and XMP: L-g1utamine
ligase (AMP) ,(Gl,I]?synthetase). The conversion of guanine to
hypoxanthine! (via GMF and IMP) was recorded by Bishop
(1961) but was studied in more detail by Hershko et al.
(1963). They demonstrated that the dialysed haemo1ysate
required the addition of magnesium, ribose-5-P, ATP and
reduced glutathione for the conversion to take place.
1.D. Compartmentalisation
The pool size of a metabolite is related to its
concentration and distribution throughout the cell. If
the distribution is uneyen then it is said to be
compartmentalised. This may represent actual physical
areas of the cell such as organelles or a distribut:..1
between bound and free fractions.
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Compartmentalisation of either form can lead to
difficulties in determining the effective intra-cellular
concentration of a substrate. For example human red
blood ceLls have no organelles except for a fEW mi.to-
chondria that may be found in reticulocytes. These
disappear very quickly in the maturation process.
Therefore .the only compartmentalisation possible' is that
of physical or chemd ca'l,adsorption to proteins t to the
cell membrane or of complex formation with metal ions.
This is exemplified. by the association of ATP and
2,3-DPG with haemoglobin which constitutes 97% of the
total red cell protein (Gomperts: 1969). Table 1.2
gives the estimated concentrations of ATP, 2,3-DPG,
haemoglobin and magnesium in human erythrocytes. The
data are taken from Bunn et al. (1971) and are relative
to cell water. Theyused the total concentration of
Table 1.2
Concentration (ml4) (in cell water)
Substance Oxygenated cells Deoxygenated cells
Total ATP 2.00 2.00
'Free' ATP 0.37 0.08
ATP.IIIg2+ 1.63 1.27
ATP.Hb 0 0.71
Total 2,3-DPG 7.20 7.20
'Free' 2,3-DPG 5.90 0.53
2,3-DPG.Ng2+ 1.30 0.39
2,3-DPG.Hb 0 6.29
Total lilg2+ 3.50 3.50
'Free' Mg2+ 0.57 1.90
these compounds and the known association constants to
calculate the concentrations of the complexes with
magnesium and haemoglobin (Hb) in oxygenated and
deoxygenated cells.
This compa.rtmentalisation has also been investigated
by Till et al. (1973) who measured the exchange of
radioactive phosphorus between phosphate esters in
intact cells. The cells were maintained under an
atmosphere of 95% °2:5% CO2 to maintain the c3:l pH.
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The specific radioactivity of the medium was kept at
a constant level. The combined specific activities of
Pi' ADP.and ATP rose to a maximum of 20% of the sp~cific
activity of the suspending medium. The specific
activity of 2,3-DPG rose more slowly but eventually
exceeded that of Pi' ADP and ATP together. Analysis of
these results and other experiments showed that 60~ of
the Pi' ADP and ATP was 'inaccessible' to the exchange
process. This result does not entirely accord with
Bunn's calculation of the compartmentalisation but both
results show that this is an important consideratidn in
the case of phosphate esters in red cells.
In addition to the possible compartmentalisation
of substrates that of enzymes should also be consi~ered.
Some enzymes are found to be associated with the cdll
membrane, as described earlier for adenosine kinas~ and
deaminase and AMP deaminase. Some glycolytic enzydes
are also associated with the bovine erythrocyte membrane
(Green et al.: 1965).
1.E. Control features of the purine pathwSl! related to,~he
function of erithrocytes
The study of metabolic control is an attempt 10
bridge the gap between enzymology and cellular fundtion.
Known cellular functions can be used with care to
direct one's investigation into controlling procesSes.
The erythrocyte has several 'functions. It compart~
mentalises the haemoglobin necessary for the transport
of oxygen and transports the oxygen and carbon dioxide
for the purpose of respiration. (The haemoglobin also
acts as the primary buffering agent for the maintertance
of blood pH~ The red cell is also used for the inter-
organ tranport of purines. Lajtha and Vane (1958) first
showed the necessity of this transport and Hendersoh and
Lepage (1959) showed that it was mediated by red cells.
In addition to cellular function the function bf
the various metabolites should be considered. The red
cell requires ATP for the maintenance of cell shape
(Nakao et al.: 1961). This is necessary for the fr~e
flow of blood especially in capillaries where the
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diameter of the vessel ~ay be as little as 4f (Fung
and Zweifach: 1971). Adenosine has been considered to
be an important vasoactive substance released by
myocardial cells during hypoxia for the regulation of
coronary circulation (Berne: 1967 cited by van Belle:
19698). ADP induces platelet aggregation whereas
adenosine inhibits this action (Rozenberg and Holmsen:
1968). It is therefore reasonable to expect a strict
control on the levels of adenosine and adenine nucleo-
tides in the erythrocyte.
'rhe control features concerned with the uptake,
maintenance and dea~ination of the adenine containing
compounds are summarised below.
('i)Al.iP deaminase is activated by ATP but inhibited by
2,3-DPG. The activated enzyme has a Km for the substrate
Al\iP of the order of O.5m.M (calculated from data of
Askari and Rao: 1968). The normal concentration of AMP
in erythrocytes, given an even distribution, is 0.01 -
O.02mM (Bartlett: 1959; Benesch and Benesch: 1967).
Normally, therefore, the enzyme
at well below its maximum rate.
of 2,3-DPG (compare information
of table 1.2) indicate that the
would be functioning
The inhibitory levels
on table 1.1 and data
enzyme is under strict
control.
(ii) There is a substrate cycle about the adenosine
kinase and 5'-nucleotidase reactions (see figs. 1.2
and 1.5). Although the rate of cycling and the net
flux of this cycle are not known, it does appear that
it has some properties which favour the conversion of
adenosine to ~dP as both a substrate and a product of
the adenosine kinase reaction (ATP and ADP) inhibit
5'-nucleotidase. However, the alternative paths for
adenosine are deamination, which is irreversible, or
diffusion from the cell.
(iii) Adenine phosphoribosyl-transferase acts either as
a s~lvage enzyme or as a detoxifying enzyme. Its
activity in certain tissues appears to be limited by
the availability of PRPP (Kelley et al.: 1968).
Although the enzyme is subject to product inhibition,
the enzyme is unlikely to be inhibited by the low
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concentration of A1IP in the cell (see table 1.1).
The 5'-nucleotidase reaction is also invclved in
a triple substrate cycle with the reactions of two
other enzymes: PNPlase and EGPRT. It is possible that
this cycle has some significance in the role of red
cells in the transportation of purines as the major
purines released from the cell are hypoxanthine,
xanthine and xanthosine. This happens regardless of
I
the original purine absorbed into the cell (Hershko
et al.: 1967).
1.F. Metabolic control and the state of the cell
The effect of the state of the cellon the control
of metabolism has been considered. Hershko et al.
(1967) found that oxygenation of rabbit erythrocytes
favoured the release of purines following the absorption
of a labelled tracer. According to Bunn's calculations
(table 1.2) the 'free'2,3-DPG concentration should be
at its highest under these conditions and ~I~ deaminase
will be inhibited. The 'free' ATF level is also high
so 5'-nucleotidase should also be inhibited.
There are clearly more factors involved here than
,
the level of these two metabolites. For exauple; Bunn's
calculation also predicts a variation in the concentration
of 'free' and ATP-bound magnesium ions with the state of
I
oxygenation of the cell. Tliis,together with the pH
shift, alter the equilibrium constant of ~dP kinase
(Rose: 1968).
Other conditions of the cell which may effect the
purine metabolism are its age and the relative abundance
or lack of glucose or other metabolites.
In studying these enzymes and fluxes it was hoped
that an understanding would be gained of the factors
governing the release and uptake of adenine and its
derivatives in the human erythrocyte.
A technique was developed to determine the inter-
conversions of a radioisotopic tracer introduced into
the pathway (chapter 5). The method was based on the
incubation of the cells or haemolysate with a labelled
purine. The conditions of this incubation could be
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varied to simulate different conditions of the cell.
The incubation was stopped by denaturing the protein
with perchloric acid. After removal of the proteih
the distribution of the label between different purine
compounds was determined. This was accomplished ~y
separation of the components by thin layer chromato-
graphy and measuring their radioactivity by liquid
scintillation counting.
This approach was backed up by the assay of
relevant enzymes~o gain information about their pbysio-
logical roles and to investigate their control.
A new approach to the assay of AFRT was tested
(2. C.) and the assay and simple partial purifieation
of A.11F deaminase is dealt with in chapter 3. A b:r':ief
comparison is made between the human and sheep
erythrocyte enzymes.
1.G.a
1.G. Cyclic-AMP
The second messenger role for cyclic-AMP
The term 'second messenger' has been coined fbr
the action of cyclic-AMP (Sutherland et al.: 1965).
It is producea in the cell by the enzyme adenyl c~clase.
For the turkey erythrocyte ¢ye and Sutherland (1966)
showed that the cyclase activity was to be found oh
the inside of the cell membrane and this appears tb
be the general site for the position of the enzyme.
The assumption that this is always the case has been
challenged by Rasmussen et al. (1972).
The activity of the enzyme is triggered by a
hormone binding to a protein receptor on the outsiae
of the cell. The hormone is therefore considered to
be the first messenger. The activation of the adehyl
cyclase across the membrane is equivalent to the
transfer of information.
1.G.b. Control of cyclic-AMP concentration
The adenylate cyclase reaction is reversible (K=b. 255,
Takai et al.: 1971; ~O.06~ Hayaishi et al.: 1971) but
the high concentration of ATP (about lO-3M) and th~
low concentrations of cyclic-AMP (about lO-7M) and PPi
(about lO-5M) in the cell mean that the reaction is
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displaced far from equilibrium and therefore is
essentially irreversible.
The concentration of cyclic-AMP in the cell is
regulated by the activity of this enzyme and by the
activity of cyclic-AMP phosphodiesterase (cyclic-AMP
PDE). This enzyme cleaves the 3'-phosphoester bond
in cyclic-AMP to give 5'-AMP. Its control appears to
be independent of the hormonal control of adenyl cyclaae.
The cyclic-AMP PDE activi ty of rat cerebral cortex is
controlled by a modulator protein and calcium (Teshima
and Kakiuchi: 1974). The same finding has been made
for the beef heart enzyme (Teo and Wang: 1973). The Km
for this enzyme was found to be 0.8~M and 25,M for the
two electrophoretically distinguished isoenzymes (e.g.
Tsou et al.: 1974). The~s for the two forms of the
enzyme from human blood platelets are 50 and 500fM
(Pichard et al.: 1973). These values are greater than
the estimated concentration of cyclic-AMP in unstimhlated
tissue of 10-7_10-6M (Robison et al.: 1971 and Lee~put-
Coutrez et al.: 1973). Therefore the rate of hydrOLysis
of cyclic-AMP is first order and this makes a significant
increase in the' cyclic-AMP concentration hard to
achieve (Newsholme and Start: 1973).
1.G.c. Stimulation of cyclic-AMP dependent protein kinase
Cyclic-AMP activates a protein kinase by bindi~g
to a regulatory subunit (or cyclic-AMP receptor) which
leads to the dissociation of the regulatory subuni1 -
cyclic-AMP complex from the remaining catalytiC subhnit.
The cyclic-AMP dependent protein kinase holoenzyme is
much less active than the dissociated catalytic subtnit
(e.g. Yamamura et al.: 1971; Gill and Garren: 1971
and Kuo et al.: 1970).
The concentration of cyclic-AMP in unstimulatea
tissue (above) is also larger than the concentratioh
required to stimulate cyclic-AMP dependent protein klnases.
in vitro. The concentration required to give half
maximal stimulation is usually of the order of 10-8~10-7M
(Reimann et al., (1971) found the value to be 1.5 and
3 x 10-8M for the two kinases isolated from rabbit
skeletal muscle). This does not necessarily mean that
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the system is unresponsive to changes in cyclic-AMP
concentration. There may be sufficient non-specific
binding of cyc1ic-Ah~ by other proteins to result in
a fairly low concentration of 'free' cyclic-AMP in the
cell. Also the stimulation of the target pathway does
not depend solely on the degree by which protein kinase
activity is increased but on the relative activities of
the protein kinase and phospho-protein phosphatase. It
may be that only a small change in protein kinase activity
is required for a significant response in the target
pathway.
The partial purification of the bovine adrenal
cortex protein kinase is dealt with in chapter 7.
Binding studies on the enzyme are presented and di4cussed
in chapter 8.
1.H. Adenylate cyclase in erythrocytes
Adenylate cyclase has been found in avian and frdg
erythrocytes (Davoren and Sutherland: 1963 and Rosdn
and Hosen: 1969). In mammalian red cells the aden1late
cyclase activity appears to be confined primarily 10
the reticulocyte fraction (Sheppard and Burghardt:
1969 and Quiring et al.: 1973). The red cells do have
active cyclic-AMP dependent protein kinases (GuthrdW
et al.: 1972 and Rubin et al.: 1973) and cyclic-AMP
PDE (Sheppard and Burghardt: 1973). Therefore it
appears that the developing red cell has a fully
responsive cyclic-AMP second messenger system but that
the adenyl cyclase is 'lost' during or soon after the
maturation of the cell. This leaves the possibility
open that the cyclic-AMP apparatus of the red cell is
required for the very purpose of maturation or for the
processes of differentiation taking place during tbe
maturation of the oe1l;-·...--.
Adrenalin has been observed to affect membrane
properties of the red cell (Allen and Rasmussen: 1971).
Noradrenalin and dibutyryl-cyclic-AMP have been sho~
to alter the ionic transport in red cells (Riddick ".i"::'
et al.: 1971 and Kregenow: 1973). These results
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indicate the possibility that general membrane changes
are occuring which may be mediated to some extent bV
the cyclic-AMF second messenger system. In chapter 5
the effect of adrenalin is tested on the transport of
purines across the red cell membrane.
Chapter 6 deals with the assay of cyclic-AMP and
includes the results of some assays of the erythrod¥te
enzyme from turkey, rat and human blood.
1.J. Bovine adrenal cortex cyclic-AMP dependent protein
kinase
A crude preparation of this enzyme was used fdr
the assay of cyclic-AMP by the saturation analysis
method of Brown et al.' (1911). The preparation us~d
was the 5,000 x g supernatant of the cell homogenate
(section6.B.a.). Some binding studies carried out
on this preparation of the protein kinase gave non~
linear binding curves (chapter8). This indicates
either the presence of multiple types of binding site
differing in affinity for cyclic-AMP, or that there is
a degree of positive cooperativity in the binding process.
Further studies were carried out on partially purified
protein kinase to examine the· cause o,f this phenomehon.
This work shows that the simple equilibria often
assumed to govern the function of the cyclic-AMP
dependent protein kinases are not an adequate model.
for the activation of these enzymes.
. ): J,. '.<~. :. : """, ...
CHAPTER 2
GENERAL MATERIALS AND METHODS
2.A. Introduction
This chapter contains general comments on the
Qaterials and methods used in the work for this thesis.
For detailed comments on the methods ~~d conditions
used in any particular experiment the reader should
refer to the relevant chapter.
2.B.a. Source of materials
Purine bases, ribonucleosides and ribonucleotides,
2,3-diphosphoglycerate, fructose-l,6-diphosphate,
theophylline, adrenalin and calf thymus histone were
all obtained from Sigma Chemical Co., London.
5-Phospho-«,D-ribose-I-pyrophosphate was initially
obtained from PL Biochemicals, Milwaukee but subsequently
from Sigma because theirs had ~.higher degree of purity.
Adenosine-5'-triphosphate was obtained from Boehringer
Mannheim GmbH. Adenosine-(8-H3),cYclic-3',5'-phosphate
and adenosine-5'-triphosPhate-y-p32 were obtained from
the Radiochemical Centre, Amersham. All other chemicals
used were of analytical or enzyme grade except where
this degree of purity was not required.
2.B.b. Preparation of buffers and solutions
All buffers and solutions were made up using
glass distilled water or twice glass distilled water.
The pH of the solution was measured using a Pye pH
meter with a combined glass and reference electrode or
a glass electrode with a reference calomel electrode.
The pH was measured at room temperature (about 16°C)
and to within O.05pH units of the stated value.
2.B.c. Source and preparation of blood cells
One day old samples of human blood were obtained
from Warwick Hospital pathology laboratory. All such
samples had potassium EDTA added as an anticoagulant.
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Out of date bank blood was also used. Rat blood was
obtained by cardiac puncture and turkey and sheep blood
was obtained on slaughter. Blood from these sources
was stabilised by sodium citrate and glUcose. One
volume of 3.135'asodium dihydrogen citrate VIas added to
nine volumes of blood to prevent coagulation. 0.3M
glucose was added to l/20th the final volume in order
to maintain the ATP levels in the cells.
Red cells were prepared by centrifuging the blood
at 300 x g for 15 minutes at 0-40C. (See section 2.B.g.
for comments concerning centrifugation.) The.super-
natant, 'platelet rich plasma' (van Belle: 1969a), and
buffy layer of~hite blood cells' covering the sedimented
red cells were siphoned off. The precipitate, 'separated
red blood cells', was resupended in about five volumes
of Kreb's Ringer (table 2.1). The resuspended cells
were centrifuged at 1,000 x g for 15 minutes. The
supernatant and remaining buffy layer were discarded.
This washing procedure was repeated twice to give
'Kreb~s ~inger washed red blood cells'. Altern~tively
the cells were washed in 0.9% NaCl to give 'saline
washed red blood cells'.
Table 2.1
Kreb's Ringer Solutions
Stock solutions Parts by volume
0.90% sodium chloride
1.15~ potassium chloride
1.22% calcium chloride
2.117~potassium H2 phosphate
3.80% magnesium sulphate.7H20
1.30~ sodium H carbonate*
0.16M sodium pyruvate
O.lOM sodium fumarate
0.16M sodium glutamate
0.30M glucose
0.1014 eodd.um phosphate buffer pH 7.4
A B
80 100
4 4
3 3
1 1
1 1
21
4
7
4
5
21
* Gassed with CO2 for Ih before mixing.
A Fortified Krebs Ringer; B Krebs Ringer
(Table t~{en from Dawson et al.: 1969)
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2.B.d. Preparation of the haemolysate and stroma
Haemolysates were prepared by the addition of
between two and nine volumes of distilled water to j
red blood cell preparation. The lysate was then
centrifuged at 3,000 x g for 15 minutes to remove 'troma.
The supernatant w.as termed the haemolysate. The
precipitate was discarded unless required as stroma in
which case it was washed with buffer or water before
use.
2.B.e. Protein determination
Protein concentrations were determined by one of
two methods. The determination of protein concent~ations
in general solutions was carried out by the method of
Lowry et al. (1951) using the Folin-Ciocalteu phenOl
reagent. The concentration of stock reagents was
changed, however, as it improved their storage. Tne
commonly used solution of copper tartrate is super
saturated at OOC and so crystallises out if kept irlthe
refrigerator. A tenth dilution of this solution w~s
found to be suitable for storage at 00• Therefore the
concentrations of stock reagents was changed to:
A 0.1% sodium tartrate in 0.05% copper sulpha~e.5H20
B 2.5~sodium carbonate in O.125N sodium hydrdxide.
A mixture of 10ml A plus 40ml B gives an alkaline
copper reagent C almost identical to that of Lowry et al•.
The second method used in the determination or
protein concentrations was to measure the absorban~e
of the protein solution at ~280nm. This method wa~
used where the protein concentration in a large n~ber
of samples had to be determined, for example the
fractions eluted from a column. It is assumed thati the
absorbance of a protein solution with a concentratLon
of lmg ml-l is 1.0.
2.B.f. Dialysis
All dialyses were carried out using Visking t~ing
which had been soaked in a solution of about 5mM ~A
and then washed with glass distilled water. Care ~as
taken to avoid stretching the tubing. Dialysis wa'
followed by a centrifugation step to clarify the sdlut~on.
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2.B.g. Centrifugation
In the preparative stages of the work all centri-
fu{:!;ationwas carried out in a Sorvall HC2-B refrigerated
centrifuge using a GSA or 8S-34 head according to the
sample volume. The rotor te~perature was kept at about
0-4oC.
High speed clarifications were carried out either
in the Sorvall or in a Beckman L-2 ultracentrifuge if a
very high relative centrifugal force was requ~red. The
Beckman L-2 was also used for running sucrose density
gradients with an SW 50L head.
The relative centrifugal force referred to in the
individual chapters corresponds to the max imum value
exerted at the tip of the tube.
Two uni'efrigerated bench centrifuges wer€;also used:
a B.T.L. microangle centrifuge and a Coleman centrifuge.
The former was used for routine work sedimenting small
volumes of particulate material: charcoal, denatured
protein and cells. The Coleman cerrtr-a.f u..»was used for
the rapid separation of blood cells froc their suspending
medium (section 6.B.).
2.B.h. Ammonium sulphate fractionation
~olid enzyme grade ammonium sulphate was used in
fractionation procedures. All such fractionations were
carried out in ice cold solutions. Additions of ammonium
sulphate were made to give the required saturation
according to a table in Dawson et al. (1969) for use at
OOC. Ammonium sulphate precipitates were collected by
centrifugation at 10,000 x g for 30 minutes.
2.B.j. Column chromatography
The supports used for column chromatography were
DEAE cellulose (Whatman DE 11 and DE 52), cellulose
phosphate (Sigma) and Sephadex G-25 and G-IOO (Pharmacia).
The DEAE cellulose was washed before use (and when
recycled) in the recommended manner. The ion exchanger
was equilibrated with concentrated buffer and the fines
were removed before packing the column.
Cellulose phosphate was equilibrated with the buffer
to be used. Fines were removed and the column when
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poured was washed with the same buffer.
Sephadex gels were swollen in the elution buffer
at 95°C to reduce the swelling time of the G 100 gel.
All columns were packed with the outlet open and
the slurry was poured carefully so as to avoid forming
bubbles and convection currents. The cellulose columns
were protected by pieces of filter paper. The Sephadex
G-IOO column was protected by a layer of Sephadex G-25.
All tubing connections were kept as short as possible
to reduce the void volume. The chromatography was
carried out in a coldroom maintained at 0-40C.
2.B.k. Thin layer chromatograp~y
Precoated plates from Machery and Nagel (Camlab,
Cambridge - distributors) were used. They were washed
before use as described in the text (section 5.S.b.).
2.B.l. Radioisotope precautions
Whenever possible protective gloves were used when
handling radioisotopes and such work was linited to
par-t i.cuLar-areas of bench space. Spillages were cleaned
up immediately. Used or waste radiochemicals were
disposed of according to the regulations laid down by
the University Radiological Saftey Officer.
2.B.m. Liquid scintillation counting
Liquid scintillation counting was carried out in
one of t~o machines: a Packard Series 4000 and a Packard
Series 2450. The series 4000 counter was used for
counting C14, H3 and double isotopes (C14 and H3). The
series 2450 counter was used for counting H3 and p32•
A simplified scheme for the molecular processes
in scintillation counting is shown in table 2.2. The
total efficiency E of the counting relates to the amount
of radioactivity in the sample S to the count rate C
S = E x C
and is the product of the efficiencies of the component
steps in the scintillation process ei•
E =nl?-(e.)
l. l.
A quenching agent is any substance present in the
scintillation vial which interferes with a step in the
scintillation process. For instance, if compound 11is
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Table 2.2
.Process
Scintillation Processes
f3 decay
~olvent excitation
~xcimer formation
PPO excitation
PPO fluorescence
POPO? absorption
POPOP fluorescence
Photocathode emission
H3 ~ He3 + f3 + n
T + f3 ~ T* + /3'
T + T* -+ D*
D* + PPO ~ ~PO* + 2T
PPO* ~ PPO + "hvl"
"h'Vl" + POPOP -+ POPOp*
POPOp* --+ POPOP + "hv "2
"hv " ~ e-2
Efficiency
(1)
e2 (2)
e3 - ~f
e4 01. A
e5 - ~f'
e6
(1) The f3 particles collide with toluene molecules losing
kinetic energy and converting the toluene to an excited
state. (T = toluene, D = excimer and no= neutrino)
(2) Energy transfer requires 'contact' between PPO and either an
excited state toluene molecule or more usually an excited
state dimer (excimer). This must occur within the
fluorescence lifetime of the excited state. The contact
distance is about 6~.
(Birks and Conte: 1968)
capable of interacting with PPO* causing tr~~sfer of
the excited state energy to M which then loses its
excited state energy by some non-radiative process.
The overall effect will be a reduction in the fluorescence
quantum yield of PPO which is a factor in the efficiency
of the transfer of energy from PPO to POPOP.
The quenching agent most generally encountered is
molecular oxygen. It is a paramagnetic quenching agent
and has a high quenching efficiency.
To relate the count rate to the amount of radio-
active sample it is necessary to know the efficiency
of the counting and the degree of quenching.
The efficiency of counting tritium samples in the
Packard series 2450 was found to be 0.65 for the channel
preset for tritium counting. An external standard
(Ra226) radiunl pellet incorporated in the machine was
used to calculate the degree of quenching. The rels.tion-
ship between the external standard ratio E and thes
degree of quenching Q was found to be volume dependent.
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The relationship for 4ml scintillntion fluid was found
to be
Q = 1.1085(1 - Es)'
Now if Co represents the observed count rate and Ct the
true count rate then
The
et = 1.1085Es - 0.1085.
equation holds true for Es varying from 0.3 to 0.9.
p32 samples were counted using the preset channel
that isotope in the Packard series 2450. No
C
for
corrections were made to allow for quenching.
Similarly C14 was counted in the series 4000 counter
without any corrections being made to allow for quenching.
The gain setting 10~~gave optimal counts for a 50: 1000
window. The counting was at 88~ efficiency.
When counting H3 samples in the series 4000, however,
quenching was significant and a quench curve was con-
structed using the channel ratio method. Figure 2.1
shows the quench curve and the machine settings are
shovm in table 2.3 together with the efficiency and
and equation relating the channel ratio to the degree
of quenching. The quench curve equation was obtained
Table 2.3
Settings of Packard 4000 for H3 counting
Channel Window Gain Background Efficienc;y Count
Red 50 - 1000 501~ 135 0.41
Green 50 - 150 100% 56 G
Blue 150 - 300 50% 44 B
The equation relating the degree of quenching Q to
the channel ratio R is
Q = (a + b.R-l + c.R-2 + d.R-3)/(R - 1)
where a = 1:0234, b= -0';.74418,c==0.095458 ,
d = -0.003471 and R = B/G-.
by using a modification of "QUENCH" a computer
programme for curve fitting quench data which is kept
in the university computer library.
Double isotope counting for samples of C14 and H3
was also corrected for quenching by the channel ra.tio
method. The settings are shown in table 2.4.
0·5
_" "- '"
o
Figure 2.1
Quench Curve for Counting H3 in toluene: 2-EE:
FPO: POPOP Scintillation Fluid
DEGREE OF
QUENCHING
',0
0·1 0·2 0·3 0·4 0·5 os
CHANNEL RATId
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Settings of Pe.ckard 4000 for Cl4 and H3 cov.nting
Channel Nindow Gain CO'J.l1.t
Red 50 - 335 50% R
Table 2.4
Green 220 - QC 15% G
Blue 220 - 370 15% B
Equation relating channel ratio (RIG) = y to
(BIG) = x is
y = (a.x + b.x2 + cox3 + d.x4)/(1 - x)
where a = -9.3141, b = 51.402, c = 90.526 and
d = 53.731.
Another progranme from the computer library "TRICAR"
was used to calculate the C14 and H3 counto from.the
channel readings.
In general it was found that there was little
variation in the degree of quenching of tritium samples
so that the quenching could be ignored without affecting
the accuracy of the results. The external standarQ or
channel ratio. were still used to ensure that the variation
was small.
The scintillation fluids used in the various parts
of this work are denoted by their contents. So: toluene:
PPO: POPOP consists of 4g PPO and 0.2g POPOP dissolved
in 11 toluene and toluene: 2-EE: PPO: POPOP consists of
8g PPO and 0.4g POPOP dissolved in 1.2 litres of toluene
and 0.8 litres of 2-ethoxyethano1.
2.B.n. Spectrophotometric measurements
A Zeiss PMQ-II u.v. - visible spectrophotometer
was used for most fixed wavelength absorption measure-
ments. An Eppendorf photometer was used for protein
estimations by the method of Lowry et al. (1951)("see
section 2.B.e.).
i" Fluorescence spectra were measured using a Farrand
Mk I f1uoro~ter~ It is a single beam instrument. The
fluorescence of a perspex block was used to check machine
drift.
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2.C. The stability of PRPP
It was proposed to assay the activity of ad enf.ne
phosphoribosyl-transfer~se by hydrolysing the pyro~
phosphate which is produced in the enzyme catalysed
reaction and determining the phosphate.
The assay for orthophosphate follows the proc~dure
of Woolfolk et al. (1966) and is shown in table 2.5.
Table 2.5
~hosphate as~ay procedure
Room temperature
To test-tube add:
0.2ml sample containing ° - 0.25pmol (25pg) ortho-phosphate
1.8ml 0.8% FeS04 in O.015N H2S04 (freshly made).Shake well.
Add O.15ml 6.6% (NH4)2Mo04.7H20 in 7.5N H2S04
Leave for 10 minutes and then measure the absorbande
at 69lnm.
It is a colourimetric assay which gives a linear
response with up to 25pg of orthophosphate.
However, it was found that PRPF, the substratd for
the enzymic reaction, was unstable to hydrolysis urtder
the conditions of the phosphate assay. Indeed the PRPP
was found to hydrolyse slowly at 0°0 in pH 7.4 bufter
(lOOmM Tris. HCl).
These findings precluded the use of a phosphate
assay as a means of determining the activity of APRT.
Subsequently all PRPP solutions were prepared shortly
before use. A note was later obtained from Sigma
Chemical Co. giving details of the stability of FRPP.
The ir data are in agreement with these resul te.•
CHAPTER 3
AMP DEAMINASE
3 •A.. Introduction
AMP deaminase catalyses the hydrolytic deamination
of AMP to give IMP and ammonia. The enzyme has besh
studied from a wide variety of sources though principally
from rabbit muscle (Lee: 1951a and Smiley et al.: 1961).
Setlow and Lowenstein (1967) measured the acti~ity
of the enzyme by the quantity of ammonia produced i~ a
fixed time. Burger and Lowenstein (1967) used a ra4io-
isotope stop assay. They separated the product from the
substrate by ion exchange chromatography. The enzym. is
more usually assayed, however, by the method of Kal~kar
(1941). He demonstrated how the differences in U.V~
absorption of the purine bases could be used in the
measurement of their concentrations in a mixed solution.
The difference in molar extinction is at its largest at
~265nm. The progress of the reaction is measured b~ the
decrease in absorbance as AMP is converted into IMP.
A comparison is made here between the U.V. abs'rption
and fluorescence properties of AMP and IMP. AMP delminase
was assayed by measuring the change in U.V. absorption at
x 2 6 5nm ( 3 •c. ) .
The assay of the enzyme in dialysed haemolysates
was hindered on several counts. This was due
(i) to the presence of very large concentratiohs
of protein
(ii) to the presence of undialysed inhibitor, even
after prolonged dialysis
(iii) to the low rate of conversion of AMP intb IMP.
Consequently a partial purification of the en~yme was
investigated. The aim was to remove the main protein
contaminant, haemoglobin, and to raise the activity of
the enzyme solution.
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A similar purification was carried out on the AMP
deaminase from sheep erythrocytes. These red cells
have a very low concentration of 2,3-DPG (Blunt et .~l.:
1971 and Rapoport and Guest: 1941).
3.B. Materials and methods
The sources of materials are as described in s~ction
2.B.a •• All the methods used in the work comprising
this chapter are dealt with in sections 2.B.b. - 2.a.j ••
3.C. Determination of enzyme activity
3.C.a. Determination of AMP in the presence of IMP
A comparison Vias made between the use of the d.v.
absorption of AMP and IM~P and the use of their fludr-
escence as a basis for their determination.
The fluorescence of ~{P is greatest in approximately
3N acid and has an excitation maximum at the wavelength
275nm and a fluorescence maximum at 390nm. !UP has
almost negligible fluorescence under these conditions.
However, the use of fluorescence measurements for the
determination of Ab~ are limited in two respects.
Firstly, the sensitivity of the fluorometer: to the
pr-eaenc e of residual protein and turbidity adversely
affects the assay sensitivity and secondly, the range
over which the assay response is linear is restricted
by the absorbance of the AMP solution.
The relative fluorescence (I 1)re
solution is given by the relationship
I = I (1 _ 10-ECd)~rel 0 Pf·
of a clear
(Udenfriend: 1961):
where c is the concentration of the fluorescent species,
€ is the extiction coefficien~ d is the optical depth
and ~f is the fluorescence quantum yield. In very dilute
solutions the second order and higher ~erms in the
exponential function can be ignored so
Irel = Io(2.3ECd)~f·
So Irel varies linearly with concentration until th~
absorbance of the solution becomes significant (c.a~ 0.02).
-28-
The millimolar extinction for AII1Pat a wavelength of
275nm is approximately 4. The optical depth in a lcm
cell is O.5cm. The concentration limit for the linear
relationship is, therefore, 20pM. The relative fluor-
escence intensity of a 20jJ11 solution of AMP was found
to be only six times the background light intensity.
This cakes the difference in fluorescence between AMP
and IMP an unsatisfactory measure of their concentration.
The U.V. absorbance of solutions of AMP and IMP
was not affected to such an extent by limiting factors.
The wavelength selected for the D.V. absorbance
measurements was 265nm. This w~velength was chosen on
the basis that it gave the largest percentage difference
between the absorbance of AMP and IMP at the same
concentration. This was the same wavelength as used by
Kalckar (1947).
3.C.b. Assay of A1~ deaminase activity
i) The assay of the enzyme activity in dialysed
haemolysates was carried out by pipetting the solutions
shown in table 3.1 into a small test-tube. The reaction
mixture was incubated at 370C for two minutes to
establish thermal equilibrium before the reaction was
started by the addition of haemolysate.
Table 3.1
Conditions used for the assay of Al4P deaminase
Temperature 37°C
Shaking water bath (c.a. 2 cis)
Solutions used:
O.5ml 200mM Tris.HCl pH 7.1
with 250m14 KCl
O.5ml lOmM ATP
lOmM AMP }
haemolysate
water
to a volume of 2.5ml
The reaction was terminated by deproteination with 8~
perchlorio acid. Denatured protein was removed by
centrifugation. The progress of the reaction was
measured spectrophotometricallY.(3.C.a.).
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ii) This assay was used for determining the activity of
fractions from columns where it avoids the use of large
numbers of centrifugation steps.
The incubation mixture was essentially the same as
above except that the volume was reduced to 1.5ml. (The
other conditions are shown in table 3.1.) The reaction
was terminated by the.removal of a 50pl aliquot which
was added to 2ml of 5mM EDTA (brought to pH 8.3 with Tris
base). The absorbance of this solution was then measured
at A265nm. A correction for protein absorbance was
made where necessary. The EDTA solution did not entirely
stop the reaction as was shown by leaving the stopped
reaction overnight and redetermining the absorbance.
However, the reaction was slowed down sufficiently to
consider it stopped over the period of time required for
obtaining the absorbance measurements.
iii) The partially purified enzyme had a sufficiently
high specific activity to enable the use of an assa;
involving the continuous reading of the absorbance tt
A265nm. This necessitated, however, the use of low
(non-saturating) concentrations of AMP and ATP (O.l~mM
and 0.12mM respectively). The change in absorbance
against time was linear for 20 minutes and varied b~tween
0.012 and 0.002 per minute. In view of the low
concentrations of AMP and ATP required in this assat it
was not often used.
iv) A correction was made by-including a control
tube in the assay incubation in which water replacel
both AMP and ATP solutions. The control tube was
deproteinated like the reaction tubes and the super~
natant was diluted in the same proportions. The
absorbance of the diluted solutions was measured at
wavelengths 265nm and 290nm. If the control absorbince
for each wavelength is A~65 and ~90 respectively ~d
the absorbance for each reaction is A~65 and A~90 at the
two wavelengths then the corrected absorbance is
A~65 = A~65 - A~90(~65 /A~90)·
This is because the contribution of the nucleotide ~o
the absorbance at A 290nm can be considered insignifj,cant.
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3.D. Partial purific.ation of AMP deaminase from human
erythrocytes
A summary of the. individual steps described i4
detail here is given in table 3.2 at the end of section
3.D.d ••
3.D.a. Preparation of the haemolysate
The haemolysates were prepared from washed red celQs
(2.B.c.) as described in section 2.B.d. The AMP daaminase
specific activity of the haemolysates varied consider-
ably, depending on the dialysis, from 0.014 to 0.194
pmol/h/mg. Some samples were not dialysed and had low
activity presumably due to the presence of 2,3-DPG ~hich
is present in red cells at concentra"tions varying between
5 and 7mB. This assumption was not directly tested
although dialysis resulted in increased activity of the
enzyme. The yield of AMP deaminase could be increased
about 10% by washing the stroma after the centrifugation
following the lysis of the cells. However, this
inVariably led to a dilution of the enzyme and cons~quent
decrease in activity of the enzyme and was not therefore
generally used.'
3.D.b. Ammonium sulphate fractionation
Addition of ammonium sulphate to 25% saturatioh to
haemolysates with 35mg/ml protein gave very little
precipitate. Increasing the concentration of ammon1um
sulphate to 55 - 57fo saturation resulted in the
precipitation of almost all the AMP deaminase activ~ty.
Haemoglobin, which accounts for 97~ of the erythrocrte
protein, precipitates at about 60% ammonium sulphat~
saturation.
The enzyme was therefore precipitated by adding
ammonium sulphate to 57~ saturation and collecting the
pale pink precipitate by centrifugation. The pellet was
resuspended in 20mK Tris.HOl pH 7.1.
The enzyme was thus purified about 30 fold with a
yield of 60% but was no longer stable to dialysis.
--- ---------"_
3.D.c. DEAE cellulose column chromatography
The dialysed haemolysate (3.D.a.) was put on a
15 x 3cm column of DEAE cellulose equilibrated with
20mM Tris.HCl pH 7.2. The column was sequentially
washed with 20mM Tris.HCl pH 7.2 and 50mM Tris.HCl
pH7~2 until no more protein was eluted. The haemo-
globin was removed by these washes. The enzyme was
eluted with 50mM Tris.HCI pH 7.2 containing 0.5M KCl.
The active fractions were pooled. The column was used
principally as a means of separating the enzyme from
haemoglobin. The conditions described above ensured
that this was done and that the enzyme was eluted in a
small volume. (See table 3.2)
3.D•d• Cellulose phosphate column chromatography
A 77ml sample of DhAE cellulose purified enzyme
was applied to the cellulose phosphate column which was
equilibrated with 50mM Tris.HCl pH 7.2 containing 0.1%
2-mercaptoethanol. The column was washed with the
equilibration buffer, lOOmM Tris.HCI pH 7.2, containing
0.1% 2-mercaptoethanol and the same buffer containing
O.4M KCI. Each wash continued until no more protein
was eluted. The enzyme was finally eluted with 1.OM
KCl in lOOmM Tris.HCl pH 7.2 containing O.l~ 2-mercapto-
ethanol.
3.E. Assay controls, enzyme activation and inhibition
1.E.a. Assay controls
The spectrophotometric assay cannot distinguish
between AMP deaminase activity and deamination of adeno-
sine produced by phosphatase activity in the presence
of AMP.
Using an EDTA stopped assay (3.C.d) the activity
of the enzyme eluted from a DEAE cellulose column was
measured using 0.95mM AMP, 0.77mM adenosine and a
mixture of both at the same final concentrations. The
activities are shown in table 3.3.
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Table 3.2
Summary of Purification Steps'
Step Volume Protein Activity Specific '1ield
conc. pm0,Ym activity
ml mg/ml ml/h pmoXI "mg/h
Haemolysate - 18 0.25 0.014 -
Dialysed
haemolysate - 62 7.4 0.194 -
Haemolysate 840 35 4.4 0.125 loo
Ammonium
sulphate 116 7.5 19 2.5 58
o - 57%
Dialysed 138 6.3 2.7 0.42 10
Haemolysate 130 62 7.4 0.119 too
DEAE
cellulose 73 3.8 10.8 2.84 84
Dialysed .
DEAE
cellulose 77
Cellulose
phosphate ,25.5 0.05 ' 12.0" 240 32''....
Table 3.3 dt
Deamination of AMP and adenosine
b~ 'DEAE cellulose enzyme'
0.95 6.00
0.77 1.17
0.95 0.77 6.18
Substrate concentration (mM) Activity
AMP adenosine AA/h/ml
The Km for adenosine deaminase is 40ym. Therefore
the activity 1.17~A/h/ml in the presence of O.77DM
adenosine should represent the maximum rate of deamin-
ation. The deamination rate when both adenosine and
AMP were present, 6.18~h/ml, should represent the
maximum deamination rates for both deaminases. The
rate of deamination by AMP deaminase alone, therefore,
is the difference between these rates and is 5.01AA/h/a.
The contribution of the adenosine deaminase (combined
with 5'-nucleotidase) to the deamination rate when only
AMP was present was 17%. In another preparation this
contribution was less than 14%.
3.E.b. Enzyme activation and inhibition
(i) The enzyme was assayed in the presence of 10mM KC1,
0.18mM AMP and 0.12mI'dATP using the continuous assay
(3.C.b.). The activity was 0.78 mo~mg/h. On the
addition of 0.95, 2.38 and 4.75mM 2,3-DPG (final concen-
trations) the enzyme w~s inhibited by 41%, 84% and 100%
respectively.
(ii) The enzyme was assayed as in (i) but with A1~
concentrations of 0.18, 0.16 and 0.08roM and ATP concen-
trations of 0.12, 0.10 and 0.055mM respectively. The
activities, 78, 64 and 12 mo~mg/~were proportional
to the product of the AMP and ATF concentrations.
(iii) The association of AMP deaminase with the cell
membrane was measured using the EDTA stop assay (3.C.b.).
The stroma had a low AMP deaminase activity which slowly
increased with time (0.21 mOl/ml/h when fresh and
0.42 mol/m~h after 1 hour at DoC). Addition of triton-
X-lOO or SDS increased the activity over threefold at
concentrations o~ the detergents of 0.001% and O.lOmM
respectively. In the presence of detergent the enzyme
activity decreased with time. Higher concentrations of
detergent resulted in loss of activity.
3·P. Sheep blood AMP deaminase: preparation and assay
Sheep blood was collected at slaughter. After 2h
the coagulated blood was chopped and centrifuged at
3,000 x g. The supernatant, serum, was removed. The
precipitate was washed twice with 4 volumes of 154m!
NaCl. The washed coagulated cells were lysed by
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homogenisation in a blender (Attomixer) with 2 volumes
of 25~~ Tris.HCl pH 7.4 containing 0.110 2-mercapto-
ethanol. Cell debris was removed by centrifucation at
10,000 x g for 20 minutes.
A portion of the sup~rnatant (25ml) was dialysed
for 2h against 2 litres of 25mLiTris.HCl pH 7.4 cor:tain-
ing 0.1% 2-mercaptoethanol. Another 25ml portion had
anmom um sulphate added to 5756 saturation. The result-
ant precipitate was collected in the same buffer and
dialysed as above. iI'heammorrium sulphate precipitate
contained a lot of haemoglobin.
The activity of the haemolysate 10,000 x g super-
riatarrtand amrnonium sulphate precipitate were measured
using the EDTA stop assay. The results are snown in
table ..3.4;
Table 3.•4.
A1~ deaminase activity of sheep blood preparations
Enzyme sample Age AIJP ATP Activity
days mbI mm !::.A/h/ml
Haemolysate before (1 0.18 ° 0.18dialysis
Haemolysate after <1 II " 0.15
dialysis
0-57/~ ammonium <1 " " 0.33sulphate ppt.
" 2 " " °
Haemolysate 5 II " 0.09
An ammonium sulphate precipitate (0-40% fraction)
was obtained from the 25ml of the haemolysate 10,000 x g
supernatant which was stored at oOe. The precipitate
was resuspended and dialysed as described above. The
dialysed ammonium sulphate precipitate was assayed for
AMP deaminase activity with the effectors shown in
table 3,5 ..
Table 3.5-
Activation of sheep blood AllLPdeaminase
I
Enzyme 1iliIP Effector Activity
m',T 0.67mlrl t:.A/h/mll.!
Ammorri.um - 0
sulphate ATP 0.253
ppt. 2,J-DPG 0
(0-40;1a) Fructose-l,6-diP 0.053
~.G. Discussion
3.G.a. The relative change in fluorescence (excitation
~275nm and emission A390nm) on the conversion of A}LP to
IMP is much larger (c. a. 947~) than the relative change
in absorbance (c.a. 60%). However, the useful concen-
tration range (0-30fId) for fluorescence measurements
is much less than that for absorbance measur-euerit s IO-12ojJM).
Protein fluorescence, which is mainly due to tyrosine
and tryptophan residues (excitation \-275 and 287nm and
emissiOn~)03 and 348nm respectively), represents a
more serious problem in the measurement of
purine fluorescence than the protein absorbance at
A265!lI!ldoes in the measurement of purine absorbance.
3.G.b. The control assay (3.E.a.) showed that 5'-nucleo-
tidase (or other phosphatases) and adenosine deaminase
contributed to the apparent activity of AMP deaminase
assayed spectrophotometrically. Generally 5'-nucleo-
tidase requires magnesium for activity. The enzyme from.
calf intestine is irreversibly inactivated by EDTA
(Center and Behal:1966). The magnesium can be reversibly
removed by exhaustive dialysis, but the dialysis steps
and other preparative stages here were either insufficient
to remove the magnesium or the phosphatase activity was
not magnesium dependent. ATP generally inhibits
5'-nucleotidase so assays with ATP should be free from
this artifact if the phosphatase is 5'-nucleotidase.
A simple but satisfactory partial purification of
human erythrocyte AMP deaminase was carried out using
a DEAE-cellulose column. The resultant enzyme preparation
3:.G.c.
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retained some of the characteristics observed by Askari
et al. (1965 and 1968). It also contained a te~in-
ation route involving adenosine deaminase.
3.G.d. Rao et al. (1968) showed that water lysed red
blood cells gave stroma fractions containing 58% of
the whole cell AMP deaminase activity. Successive
washes of this fraction reduced the activity to 16~ of
the total activity. Lee and Nang (1968) treated part-
iculate fractions of rat brain ~~d liver with various
detergents to examine their effect on the ~I~ deaninase
activity. They concluded that the detergents released
activity from the particulate fractions and that anionic
detergents SDS and deoxycholate inhibited the enzy~e
possibly by dual interactions with the substrate and
activator sites. The inhibition was effective at
approxi~ately millimolar concentrations of the <ietergents.
Here SDS increased the activity of erythrocyte
membrane A!i!P deaminase but inhibited at ImM. Ttere was
also a time dependent loss of activity, preswnably due
to denaturation of the enzyme. Triton X-100, a non-
ionic detergent, also gave increased activity at 0.01%
but inhibited at higher concentrations. The time
dependent loss of activity was also seen with triton.
3.G.e. 'l'hemaindifference observed between sheep eryt:h.-
rocyte AMP dearuinase and human erythrocyte Ai·II'deaminase
was the lack of activity of the sheep enzyme in the
absence of ATP. This has also been found fo~ the 2r.zyme
from cat and dog erythrocytes (Askari and Franklin:
1965). Sheep erytlrrocytes have a much lower concentration
of acid soluble phosphate esters (15.4mg/lOOlll) than
human erythrocytes (55mg/lOOcl). The normal concen-
tration of ATP and 2,3-DPG in sheep erythrocytes is
8.4 and O.8mg/100ml respectively (Rapoport and Guest:
1941). Using a conversion factor to convert this to
millimolar with respect to cell water (Bunn et al. 1971)
the concentrations in sheep red cells are ATP 1.24mM
and 2,3-DPG O.2mliI(c.f. table 1.2). This means that it
might have been expected that sheep erythrocyte ~\~
deaminase has different regulatory properties to the
hum~ enzyme as appears to be the case.
CHAPTER '4
AN ATTEMPT TO DETERMINE THE FLUX IN
PURINE PATHWAYS
4.A. Introduction
A technique for the separation of purine ribo-
nucleotides, ribonucleosides and b~ses was developed.
This technique was used to estimate the interconversions
of radioactively labelled purines followinC an incubation
of red blood cells with a labelled purine base. While
this technique does not indicate the true flux in any
pathway it does serve to indicate the relative import-
ance of different paths.
Flux studies using radioisotopically labelled sub-
strates have been used to show that purine bases are
incorporated primarily into the corresponding nucleotides.
Hypoxanthine was the only base which was significantly
incorporated into the nucleotide fraction corresponding
to a .different base, namely guanine. This requires the
prior formation of IMP and its subsequent conversion to
GMP (Bishop: 1960). Lowy et al. (1958) demonstrated
that adenosine uptake was dependent on the concentration
of phosphate. Uptake was Greater in phosphate buffer
than in physiological saline. Only 20% of the adenosine
was converted to nucleotide. The remainder was deamin-
ated. These results were obtained by analysis of intra-
and extra-cellular ribose, lactate and aLtmonia. Van
Belle (1969~ demonstrated the rapid assimilation of
adenosine by the blood cells of a variety of different
species usinG an automatic colourimetric assay for
adenosine (van Belle: 1969~. As adenosine is a vaso-
active agent in regulating the coronary blood supply,
its rapid uptake is an essential control on this action.
Hershko et al. (1967) used C14 labelled purines
to demonstrate the pattern of uptake of purine bases in
vitro and their subsequent release. Hypoxanthine and
xanthine were the products released regardless of the
purine incorporated into the cell. Some xanthosine was
also released but this was shown to be due to the lack
of glutamine in their inCUbations. Bertles and Beck
(1962) have snown that in the maturation process of
rabbit reticulocytes the only purine released from the
cells is hypoxanthine. 'I'he quantity released was prop-
ortional to the IWA breakdown in the cells. Hershko
et al. (1963) examined the conversion of gu~~ine to
hypoxanthine. It was shown to take place via GLP and
li:,lP. ltJ:ostof the guanine was converted to GT.P.
These studies on purine flux have demonstrated the
possible functions of some of the pathways but the
actual control and interrelationship of the pathways
remains open to investigation. Subject to the limit-
ations of examining flux by analysis of the products
from a radioisotopic tracer (see discussion 4.D.) it was
hoped that some headway might be made in understanding
the controlling factors relating to the stabilisation
of the adenine nucleotide pool and the control of the
deamination routes.
4.•B. .lIlaterialsand methods
4.B.a. Incubation of labelled purine with red cell nreparation
Washed red blood cells from human one day old
blood samples were prepared as described in section
2.B.c. and haemolysates were prepared as described in
section 2.B.d.
The incubation was carried out by adding 10 or 50pl of
Cl4_labelled purine base (2.4mL1and 3.7}JCi/}Jmol)*to Iml
of a 1 in 10 (or 1 in 4) suspension of red cells in
Kreb's :Ringer,or an equivalent haemolysate, in a small
test-tube. The incubation was carried out at 37°C in
a water bath with agitation.
The incubation was teminated by one of two methods.
One was to add 0.5ml of 2.4M perchloric acid. The other
was to separate the cells from the suspending medium by
refrigerated centrifugation (5 minutes at 3,000 x g) and
the supernatant removed. The cells were washed once with
Kreb's ~inger and resuspended to the original volume of
the incubation mixture, O.5ml of pechloric acid was
then added to the first supernatant and to the resuspended
cells. All these operations were carried out at OoC and
as quickly as possible. The precipitated protein was
* Obtained from the Radiochemical Centre, Amersham.
•re~oved by centrifugation and the supernatant decanted
off and neutralised with L~C03. The neutralised super-
natant was cooled to OOC and the crystallised KCI04
re~oved by centrifugation.
In general the final supernatant was reduced in
volume on a rotary evaporator before separating the
radioactive components.
4.B.b. The separation of purine bases, nucleosijes ~~d
nucleotiues by thin layer chromatography
i) Choice of method
There are a number of systems available for the
separation of purine compounds (Randerath: 1964; Stahl:
1961; Randerath and Randerath: 1967; Lederer and
Lederer: 1957; Caldwell: 1969; hIeyskens and 'l:illiams:
1971; Hershko et al.: 1967 and others). 1'hetechnique
chosen was that of Crabtree and Henderson (1971) who
used one dimensional tlc to separate the purine nucleo-
tides and two dimensional tlc to separate the nucleosides
I
and bases. 1he advantages of this system over other tlc
methods are twofold. Firstly, the streaking of the spots
is minimal. Secondly, it is not necessary to make an
initial separation between the bases and nucleosides and
the nucleotides. It is therefore relatively speedy and
simple to use. The advantage over column chromatography
(such as Caldwell: 1969) was that the separated compounds
could be cut from the tlc plates and counted without the
problems involved in counting dilute aqueous samples.
ii) Pre-treatment of the tIc plates
Precoated plates (see section 2.B.k.) were used.
They had to be washed before use for the best results.
The PEl-cellulose sheets were developed for five
hours with 4hisodium formate buffer pH 3.4. Il'heplates
were dried and developed overnight with 50% methanol.
The sheet was dried before use.
Cellulose sheets were washed either with distilled
water or the solvent used in the first dimension of the
separation.
iii) Separation of purine ribonucleotides
The PEl-cellulose sheets were marked lightly wi~~
a very soft pencil with lines 2.0, 4.5, 9.0 and 19.0cm
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from the base of the plate. A wick of dhatm211 3Ml'LI
chromatography paper (approximately 7 x 20cm) was stapled
to the top edge of the sheet. Carrier nucleotides in
a solution containing 30runol of each nucleotide were
applied to spots on the 2.0cm line so that the spots
were at least 2.0cm apart. In this way up to nine
srunples could be chroQatographed on the s~e plate.
Thes~ple (prepared as described in section 4.B.a.)
was then applied to the spot. The plate was washed
overnight with 50~:'methanol and the wick c crrtain.i.ngthe
purine bases and nucleosides was discardc6, ru~d the
plate dried.
The plate was developed by stepwise elution with
sodium formate buffer pH 3.5 as follows:
0.5M to 2.5cm line above the origin,
2.011
4.0M
" 7. Ocm
" 17.Ocm
" " II II
" " 11
The plate was then dried and the separated nucleo-
tides were visualised under ).254nm U.V. light.l'he
spots were circled in pencil. The elution pattern is
shown in figure ~.l.
iv) Separation of purine bases and nucleosidcs
The cellulose sheets (section 2.B.k.) were cut into
two 10 x 20cm plates. Carrier bases (30nmol each in
I-butanol solution) and carrier nucleosides (30nmo: each
in aqueous solution were applied to the origin which was
a spot 2.5cm from either edge of the sheet. The sample
was then applied to the spot. The solvent for the first
dimension (20cm) was acetonitrile: O.lhl ammoniun ~cetate
pH 7.0: ammonia (SG 0.880) in the ratio 60:30:10 by
volume. The plate was developed for 50 minutes in this
solvent and dried.
The areas below the origin and 3cm from the top of
the plate were removed. The plate was then develope6. in
the second solvent which was composed of I-butanol:
methanol: water: ammonia in the ratio 60:20:20:1 by
volwne. The plate was developed to the top, dried and
redeveloped in the srunesolvent. After drying the sheet
the spots were visualised under ~254nm D.V. light. T~e
elution pattern is shown in figUre ~.2.
Pigure 4.1
Elution Pattern for Purine Nucleotides
on PEl-cellulose tlc
o o
33
o o
Al',IP IlVIP GIdE ADP GDP ATP GTP mixture
0 = origin
31 = limit of solvent 1 (O.5M sodium formate buffer pH 3.5)
32 " " " 2 (2.0M " II " II II )=
33 = II " " 3 (4.0lYl " II II " " )
•
Figure 4,.2
Elution Pattern for Purine Bases and Nucleosides
on cellulose tlc
Solvents:
1) CH3CN: O.lM CH3C02.NH~, pH 7.0: NH40H (S.G. 0.88) 60:30:102) l-butanol: methanol: water: ammonia (S.G. 0.88) 60:20:20:1
First
dimension
(solvent 1)
Nt
o
Second dimension (solvent 2) twice
(Nt = nucleotide)
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4.B.c. Liquid scintillation counting
The separated purine compounds were cut out from
the tIc sheets in 1cm squares. (The backing of the tlc
sheets was polyterephthalic acid and could easily be
cut with either scissors or sharp knife.) The squares
were placed into empty scintillation vials and the
scintillation fluid was then added. The scintillation
fluid was 4m1 toluene: PPO: POPOP (see section 2.B.m.).
4.0. Results
The results of three incubations are shown in tables
4.1, 4.3 and 4.4. These tables contain details of the
incubations and the results as described below.
i) (Table 4.1) Kreb's Ringer washed cells (2.B.c.),
haemolysate (2.B.d.) and dialysed haemo1ysate were
incubated with C14_adenine and C14_hypoxanthine under
the conditions described above (4.B.a.). Th,e incubation
was terminated by the second method described there so
as to measure the distribution of the label between the
cells and the suspending medium. This is shown in the
table together with the distribution of the label between
the various compounds.
The uptake of adenine by rat erythrocytes (chapter
5: table 5.2) approached equilibrium in about 40 minutes.
It is likely, therefore, that the percentage uptake
shown here is an equilibrium value as the incubation
time was 75 minutes.
A calculation of the change in concentration of the
labelled adenine or hypoxanthine in the suspending medium
and the apparent change in concentration of the labelled
compound inside the cell shows that the incubations of
12pM label may have attained equilibrium across the cell
membrane but the incubations with the 114pM label have
not (table 4.2).
The uptake of purine was l4nmol/(ml of erythrocytes)
in the case of the 12pM adenine and l2nmol/(m1 of
erythrocytes) in the case of the l2pk hypoxanthine.
These figures correspond to the total uptake of purine
and not to a rate of diffusion across the membrane. The
comparable figure for washed rat red cells is 54nmol/ml.,
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Table 4.1
Incubation of Red Cell Preparations with Purine Bases
Suspension medium: Kreb's Ringer B*+ 5% of 5.4% glucose solution
Cell preparations: A: 2ml 1 in 4 suspension of Kreb' s Ri.ngerwashed
(* see table 2.1) cells. B: 2mllin 5haemolysate. C:2mllin 5haemo-
lysate (dialysed against ph<mphatebuffer pH 7.4).
Also used D: 2ml ser~ and E: 2ml ringer.
C14-adenine and C14_hypoxanthine (3.7~Ci/~mol)
G h I b t' 7
Tracer:
J.:emperaure: . aseous p ase: aJ.r. ncu at i on a me • 5 rm.nut es.
Sample Fraction Recovery % % Predominant
of counts uptake Coversion compound s
% to nuclt. '_
A + Cells 12 12 4.5% ±1.5 A}.I~P: ATP = 2:1
l14yM ado:ade:inoadenine 16 10:9:1=
Supernatant 4 - 0 ade
Cell wash 0 - 0 ade:hyp = 6:1
A + Cells 29 29 14~1o ±7 AMP:ATP = 2:1
l2~r ade: ino = 7:2
Supernatant 66 94 0 adeadenine -
Cell wash 0 - 0 ade:hyp = 6:1
B+ 114fllYhaemolysate 55 - 1 AlflP:ADP:A'l:P
adenine ::: 7:3:2 -
B + 12fJM " 99 5
AL'Q>:.ADP :ATP-adenine = 2:1:1 _
C + 114}JIYIDialysed 93 - 0.2 AMP; ade:hyp:ado:, ino 67:2:10:1adenine -hae:nolysate = .
C;-l~}JLl II 104 1 AMP; ade:hyp:ado;- ino 55:2:3:1aa.enJ.ne = -
A + Cells 14 14 5 Bll": G1,LP: GTP= 3:4:3
l14fM 100 hyp:ino:guo/guahyp ::: 2:1:1
Supernatant 86 - 0 hyp
Cell wash 0 - 0 -
A + Cells 25 25 4.5% ±3.5 I l:i.iP : GMP : G 'r P= 4:1:1
l2f.1M 99 hyp,-hyp, Supernatant 74 - 0 II
Cell wash 0 - 0 -
B + 114~lrIHaemolysate 116 0.5 1111' : G rl.' 1-' = 2:7- hyp: ino:guol guahyp. - 11:2:1_
B hy~2f'M " 58 - 0.2 IhlJl ; hyp
C + l14fhl Dialysed 98 - 0.3 lllI}J : \z '1\}- - 1- -• _Jhyp haemolysate hyp: ino~guoigua
~ ":l,.
C + l2f1M " 74 - o. 5 r:.liP: GTP = 1:1hyp hyp: ino:guo/gua=6: 5: L'
I --
t
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Table 4.2
Uptake of Labelled Purine Ba~es by Human Erythrocytes-
C14 Volume Time Concentration Apparent
Conversion to
of (min) in suspending concentration nucleotide
for
l'racer'fr8.cer medium in cells equilibrium
ade lOOfl 0 150flli - -
75 l32jJM 58}JM Not equm.
ade 10fl ° 15.9fh1 - -75 11.3jJlI1 l4.0}JlH 1.35nJIlOl( 5. 6%~
hyp lOOf'l 0 l50fM - -
75 129p1\1 68}JM Not equm.
hyp 10fl 0 l5.9~hl - -
75 11. 9jJM 12.0}'M 0.05nmol (0 2°.'~• /1»)
Thi~ correlates with the difference in the content of
acid soluble phosphorus (particularly TP) between rat
erythrocytes and human erythrocytes (Rapoport and Guest:
1941). They measured the concentrations of ATP in rat
and human erythrocytes. The concentrations were
34.1 and 13.5mg/100ml respectively. (These are equivalent
to 3.67 and 1.45mM.)
The amounts of adenine and hypoxanthine taken up
were compa.rable, but more of the adenine (25-60%) than
of the hypoxanthine (4-35%) was converted to nucleotide.
This is surprising considering the relative activities
of AJ?RT and HGPRT in the human erythrocyte. A more
expected result was the lower conversion to nuc1eotides
in the haemolysate and dialysed haemolysate incubations.
ii) (Table 4.3) Kreb's Ringer washed cells (2.B.c.) in
a 1 in 10 suspension were incubated with O.114mlVl
H3-hypoxanthine (83.3f'Ci/~mol). The conditions of the
incubation are described in the table and in section
4.B.a .• Four separate blood saJIlpleswere used. The
cells were not separated from the suspending medium before
the addition of the perchloric acid. The table shows
the percentage of the total counts for each incubation
mixture that was found in the nucleoside sheet corresp-
onding to hypoxanthine, inosine, nucleotides, adenine
and adenosine. Separate chronatographic runs of the
mixtures to determine the nucleotides showed that t~ere
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'l'able<t.3
Blood Percentage of total counts Poor, - . separationsample hyp ino DIP ade ado between
76.5 3.8 18.9 0.3 0.6
1 70.5 5.4 22.4 1.8 0.6
e>7 .1 2.3 9.8 0.5 0.2
2 47.5 l,h§_ 16.4 2.2 0.2 hyp + ino
83.0 4.3 8.2 4.5 0
3 88.0 3.4 6.9 0.7 0.9
2...h± 8.6 ~ 4.5 1.5 hyp & IMP?
4 '2lJ.. ~ 10.5 1.0 1.2 hyp & ino
90.9 2.9 5.0 0.4 0.8
Overall 82.7 4.4 12..3 1.8 0.7average ±7.8 +2.1 +6.2 ±.l. 7 :!:0.5± S.D.*
* Averages do not include counts where there was
a poor separation of the cooponents concerned,
those being the figures underlined. They are more
than 3 x S.D. from the average given.
was negligible incorporation into any nucleotide apart
from IMP.
A discrepancy appeared in the determination of the
hypoxanthine and inosine counts in samples 2 and 4.
This was because of the rather close proximity of the
chromatographic spots. Figure 4.2 shows the position
of these spots as found for aqueous or I-butanol solutions
of the compounds. 'I'heimpurities in a cell extract
caused the slurring of the spots so that complete
resolution was not always possible.,
I The conversion to aden.Lneand adenosine was barely
significant. The counts involved were little over the
background count and the percentage conversion was almost
equal to the standard deviation.
iii) (Table ~;.4) Four samples of blood were prepared and
incubated in the same way as for ii) above except
that, one sample was incubated with 50~1 H.3-adenine
(2.4mM, 83}JCi/}Jmol)and with 50}'1of C14_adenine (2.4rrJ'Il,
3.7?Ci/jJmol) in separate tubes. Samples 2 to 4 were
incubated with C14-adenine only. When the inCUbations
were stopped aliquots from the incubation rnedi.urawith
H3-adenine were cochromatographed with eac!1of the other
incubation media.
'l'he table shows the count rate for the C14_purines
with an above background count. Adjacent to each count
rate is the ratio between that count r.ateand the count
rat~ for H3-purines formed by incubation with sample one
and cochromatographed with the C14-labelled samples.
Table 4.4
----I-n-c-u-b-a-t-i-o-n-w-i-t-h-C14- and H3-adenine -~0 get C14- and
H3-purine ratios
Sarnp1e 1 Sample 2 Sample "' Sample 4_)
Protein 10.5mg/ml 25.5mg/ml 30.1mg/ml 26.9mg/m1concentration
c~ c~
!
c~ c~
Compound Count Count Count ! Count
rate H3 rate H3 rate i H3 rate H3(C14) (C14) (C14) (C14)
Base Sheet
adenine 3690 0.350 3875 0.414 3550 0.382 3695 o. 38~
inosine 49 0.290 2 0.061 24 0.142 22 o .19~
hypoxanthine 125 0.369 69 0.376 15 0.374 16 0.19:
nuc1eotides 174 0.322 220 0.559 147 0.386 152 0.48:
Nucleotide sheet
AI/iF 52 0.138 69 0.195 80 0.197 82 o. 26~
ADP 53 0.205 67 0.630 57 0.485 .;-, o. 49~...
ATP 99 0.313 101 0.900 87 0.433 1"" 0.66'c..v
IMP 14 0.189 11 0.275 15 0.218 27 o .15~
Average ratiOj 0.279 0.420 0.328 0.35l±S.D. ±0.081 ±O.250 ±0.115 -o.i 7~
The object was to see if the ratio between the C14_
purine count rate and the H3-purine count rate was
constant within a sufficiently narrow range for it to be
used as a means of detecting different fluxes. This may
have use in the study of control factors and as a
diagnostic tool for metabolic disorders.
It would be expected that with identical blood
samples the specific activities of the derivatives of
a C14-tracer and an H3-tracer would vary in a similar
mann er. 1'hisfollows if there are no kinetic isotope
, , -
_'.' . :_:_:;
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effects or tritium exchange between the H3-tracer and
the solvent. The ratio between the 014 and H3 count
rates should, if that is ~he case, .be constant.
Take a simple example of a reaction in a pathway
in which a compound I is converted into another compound
_q.
A tracer p* (mol) with a specific activity of p
(Ci/mol) will combine with any endogenous P on addition
to the reaction mixture to give a total amount of P,
PT = P + P*. The specific activity of PT will be
P'=p.P*/P~,= p.P*/(p + p*). This assumes that the tracer
and endogenous I are thoroughly mixed.
In the enzymic conversion of PT to Q* the specific
activity of Q* formed from PT will be the same as the
specific activity of PT' pt, if there are no isotope
effects. Now if there is endogenous ~, the specific
activity of the total amount of ~, QT will be q' given by
q'= p'.Q*/(Q + Q*).
The total radioactivity associated with ~ will be
q'.(Q + Q*) = pt.Q*. It is clear that this quantity is
dependent on the isotopic dilution of the tracer P* (pt)
and on the amount of ~ formed from I in a given time
(Q*). A measurement of the total radioactivity is,
therefore,~a means of determining the flux of a pathway,
and its state. The use of two isotopes enables the
cQmparison of the same pathway in two different cell
samples. The cochromatography of the two isotopes is
to help eliminate errors due to manipulation.
The protein concentration of the reference sample
(sample 1) was considerably lower than that of the other
three samples. This was reflected in the average ratios
shown in table 4.4. However, the standard deviations
for the ratios are as large as the differences that are
due to the protein concentration. The standard deviation
for the reference ratios was found to be lower than that
for the ratios of the other aarap'Lee , This "may be .a
reflection of the varience to be expected in 'normal'
samples, or else it may be due to real differences in
"'the',fluxes of the samples.' llhe errore iAvo1ved, however,
were too large for the technique to be of practical use
without considerable refinement.
4.D. Discussion
The results have been discussed to a certain extent
in their respective sections. The conversion of the
purine bases primarily to their corresponding nucleotides
was evident in all the results. This is in accord with
the work of Bishop (1960) and Henderson and Lepage (1959).
It is clear from the tables 4.1 and 4.2 that the
0.114mM purine bases had not attained equilibrium across
the erythrocyte membrane. Therefore the transport of
purines across the cell membrane should also be considered
in a study of the flux of these pathways.
The results of these experiments do not give a
direct measurement of the flux in a pathway, but in
suitably controlled experiments the determination of
flux would be quite feasible. A number of difficulties
were encountered in this work and they-are discussed below.
The chromatography of the nucleosides and bases
was the poorest part of the separation proeedure. This
was partly due to the slurring of the spots which prob-
ably resulted from impurities carried over from the
incubation medium. It was also due to the use of half
sheets and quarter sheets rather than whole sheets.
This was a fiscal economy. In the same way the specific
activity of 014 labelled compounds was kept at 3.7pCi/fmo1.
An increase in specific activity may have enabled a more
accurate determination of the minor products in the
reactions.
Tritium labelled tracers were used to try and
improve this situation but a tritiated tracer with a
specific activity of 83fCi/~mol only resulted in a three-
fold increase in counts. This was due to the severe
quenching that occurred when counting tritium adsorbed
to a solid support.
In attempting this work the limitations imposed by
the use of radioisotopic tracers was recognised. For
example, they give no measure of the actual pool sizes
and therefore of total flux. They do, however, enable
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the estimation of the proportion of any pool metabolised
in a particular direction along a pathway. Inherent in
their use are the problems of re-utilisation of the
isotope in cyclic paths and the exchange of the isotope
with the solvent (in the case of tritium particularly).
These are serious drawbacks. An alternative technique
would have been the enzymic or chemical analysis of the
compounds involved but even quantitative analysis does
not elucidate the effects of compartmentalisation.
A further problem was the time inVOlved in the use
of this technique. On the one hand it recommended itself
in that washing procedures could be carried out overnight
(4.B.b.) and actual chromatography stages were of
relatively short duration. On the other hand they
required careful observation and the sample and carrier
application was time consuming. To compensate for the
low counts in the minor reaction products the volume of
the stopped reaction m1xture was reduced using a rotary
evaporator.
The quantitative separation of the purine bases,
nucleosides and nucleotides was found to be feasible but
not practicable. The study of the control of purine
metabolism hinged on the success or failure of this
technique.
CHAPTER 5
THE TRANSPORT OF PURINE8 ACROSS BLOOD CELL MEMBRANES
5.A. Introduction
The transport of purine bases across the erythrocyte
membrane ha::!been shown to be a rapid simple diffusion
process (IVhittam: 1960). Lassen (1961 and 1967) and
Overgaard-Hansen and Lassen (1959) have shown that
while hypoxanthine diffuses across the red cell
membrane, uric acid is actively transported across the
membrane.
Red blood cells have been implicated in the trans-
port of purines throughout the body, as shown by
Henderson and Lepage (1959). They injected mice with
C14-adenine and followed its incorporation into red
blood cells and other tissues. Felig et al. (1973)
have shown that erythrocytes are important in the
transport of aminoacids in humans. Alanine, representing
about 40% of the arninoacids released by muscle, was
transported primarily to the liver where it would be
used for gluconeogenisis. A significant difference
between this arninoacid transport and purine transport
is that although all of the purine bases are absorbed
by the red cell, Hypoxanthine and xanthine are the
maj9r purines released by the cell (Hershko et al.: 1967).
As a measure of transport the uptake of C14_
adenine by rat blood cells is measured. The kinetics
of the process is in agreement with it being diffusion
limited.
5.B. Itlaterialsand methods
Rat blood, obtained by cardiac puncture, was
treated as described in section 2.B.c. to obtain
'separated red blood cells' and 'Kreb's Ringer washed
red blood cells'. (8-C14)-Adenine was obtained from
the Radiochemical Centre, Amersham.
-4~-
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~he cells were incubatcd by pipetting the solutions
described in table '5.1into a test-tube. The incubation
was terninated by removing aliquots at set times and
layering them on lOOyl of dibutyl phthalate in Goleman
centrifuge tubes. The tubes were centrifuged at the
time recorded for the end of the incubation. Using this
technique it was possible to effect a separation between
the red cells and their suspending medium within 15s.
An aliquot of the suspending medium was counted for
radioactivity. A total count was obtained for each
incubation by counting an aliquot of the whole incubation
mixture.
'rable 5.1
Conditions used for the Transport Assay
Temperature:
Gaseous phase:
Solutions used:
0.2m1
O.05m1
blood cells in 50% suspension (by volume)
lmM adrenalin (optional)
0.70 or 0.75m1 serum or Kreb's Ringer A (table 2.1)
Preincubate to equilibrate temperature
0.05ml C14_adenine (8.5nrnol, c.a. 80,000cpm.)
Dibutyl phthalate is a hydrophobic liquid with a
density of 1.046g/ml which is between that of red cells
and water or serum. It has been used by other workers
for the separation of red cells (see Danon and
llarikowsky: 1964 and Gunn and Tostesson 1971).
A mixture of dibuty1 phthalate, lml, and 50~1 of
C14-adenine in Iml of 0.9% saline were thoroughly mixed
using a vortex mixer. The two phases were separated by
centrifugation and an aliquot from each phase was counted
to see if a significant proportion of the adenine was
found in the dibutyl phthalate layer. The dibutyl
phthalate was found to contain less than 1.5~~of the
radioactivity.
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5/ • C. Results
Blood cells were incubated with 9.4jJM C14-adenine
in the presence and absence of 55pM adrenaline The
cells were prepared in the different ways described in
the methods section (5. B.). :eigure 5.1 shows the
result of an incubation of C14-adenine with washed red
blood cells and adrenaline bach incubation gave results
which produced a straight line on a semilog. plot. The
uptake, measured by the decrease in the COun~3 in the
suspending medium, was approaching equilibrium at about
40 minutes after the addition of the labelled adenine.
The data from these incubations is summarised in table
'~2. All the figures represent the average of duplicate
experiments.
Table 5.2
The Uptake of Adenine by Red Cells in the
presence and absence of Adrenalin
Cell Gradient Ceq t1c out (L\ Cin)app (lICinll
Uptake
condition semilog.plot
. -1 fM ]JM jJM %m~n eq_
Whole + Adr 0.104 7.3 2.4 21.6 3.0 25
blood - Adr 0.079 6.8 3.0 27.0 4.0 31
Rbc in + Adr 0.048 4.9 4.3 38.7 7.9 47
serum - Adr 0.038 4.6 4.4 39.6 8.6 49
Washed + Adr 0.077 3.9 5.5 49.5 12.7 59
rbc - Adr 0.086 4.4 5.3 47.7 10.8 55
The gradient of the semilog. plot (min-I) corresponds to
b in equation (.1,) below. Ceq is the equilibrium concen-
tration of adenine in the suspending medium estimated
from the equilibrium count rate. ~C t is the differenceou
between the initial a.denine concentration and.C •eq
~Cin)app is the apparent change in internal adenine
concentration calculated fr~m ~Cout and the volume of the
cells and the medium. The percentage uptake is the
percentage of the total counts removed from the suapend i.ng
medium.
Figure 9.1 (a)
The Uptake of Adenine by Rat Erythrocytes
in the Presence of Adrenalin
Conditions as described in text.
Initial concentration of adenine
9.4~M, equilibrium concentration
3.9pM, gradient of straight line,
. -1b = 0.076mIn • Concentration of
adrenalin 55f'M.
0.5
o
-0.5
o 10 20 30 40
Time (minutes)
Error bars show the deviation of duplicate
experiments.
Figure 5 .1 (b)
The Uptake of Adenine by Rat Erythrocytes
in the Absence of Adrenalin
Conditions as described in text.
initial concentration of adenine
9. 7f1lil, equi1ibriurn concentrat ion
4.41M, gradient of straight line,
b = 0.086min-l•
0.5
o
-0.5
o 10 20 4030
Time (minutes)
Error bars show the deviation of duplicate
experiments.
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The equation to which the results were fitted in
order to get a straight line was:
10glO(Cout - Ceq) = 10glO(Ctot - Ceq) - bt (1)
where Ctot is the initial or total concentration of
adenine, t is the time in minutes and the other terms are
described in table 5.2•• The adenine did not reach an
equilibrium distribution between the cells and the medium
so the results were fitted to the equation manually to
determine this constant. The gradient of the line, b,
is related to the permeability constant (5.D.).
If the volume of the packed cells is t~~en to be
an approximate meatiurement of their internal volwne then,
asswning that the internal compartment is well mixed,
the apparent change in the internal concentration of
adenine ( Cin)app is given by:
(C) = - C x Voutin app out V.~n
(2)
where Vout and Yin are the volumes of the suspending
medium and the internal cell compartment respectively.
'The ratio (Cin)ap~Ceq gives the minimum factor by which
the internal concentration of adenine exceeds the equilib-
rium concentration in the suspending medium.
In making these calculations the count rate was
directly related to the concentration-:as the degree of
quenching was nearly constant.
5.D. Discussion
The diffusion of any substance into red cells is
governed by the relationship (Whittam: 1964):,
se. FA--!a = --CC - C. ) (3)dt v. out an
~n
From equation (2) it ean be seen that:
dCin '.= _ .Vout(dCout)
dt V. dt~n
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It follows that
dCout
dt =
FA (C. - C )an outVout
Equation (1) may also be written in a differential form:
dCout
dt
(6)
Comparing equations (5) and (6), b is related to the
permeability constant:
P A
Vout
where A is the total surface area of the red blood cells
and V is as before. As the cell volume was not. out
monitored the permeability constant cannot be accurately
b =
determined.
The other difference betw·een equations (5) and (6)
is that in equation (6) C is used in place of C .•eq ~n
This is necessary because as shown in table 5.2 the
calculated apparent internal concentration of ~denine,
though only an approximate figure, exceeds the external
concentration of adenine by a factor of between 3 and
12 at equilibrium. The approximation is that the
i~ternal cell volume is the same as the packed cell
volume and that this did not change during the experiment.
Simple diffusion must always take place down a
concentration gradient. It cannot create an adverse
gradient, therefore, the excess label in the red cells
must be in a chemically modified state so that it cannot
diffuse across the membrane. The enzyme, APRT, is
responsible for the conversion of adenine to AMP and
Bishop (1960) has shown that adenine once incorporated
into the cell is rapidly converted into AUF. It appears,
therefore, that the equilibrium level of adenine is
related to the availability of substrates required to
convert the internal adenine to other compounds that
cannot diffuse out of the cell. This is in accord with
the finding (table 5.2) that the percentage uptake at
equilibrium was highest for washed red cells and lowest
for fresh whole blood.
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The evidence obtained here does not exclude the
possibility that the adenine is incorporated into the
cell by carrier facilitated diffusion. Facilitated
diffusion is indistinguishable from simple d.iffusion
at concentrations of the substrate much lower than the
dissociation constant of the membrane bound carrier.
Adrenalin was tested for any effects it might have
on adenine transport because it has been observed to
alter red cell deformability (Allen and Rasoussen:1971).
This was observed in the absence of adenyl cyclase
activity. Also noradrenalin and dibutyryl-cyclic-M~P
have been shown to cause an increased flux of potassium
into duck erythrocytes (Riddick et al.: 1971 and
Kregenow: 1973).
Adrenalin does not appear to affect the diffusion
of adenine into rat erythrocytes.
CHAPTER 6)
THE ASSAY OF CYCLIC-An~ AND ADE~~LATE CYCLASE
B.A. Introduction
There are numerous methods available for the assay
of cyclic-AMP. It can be determined by a radioisotope
dilution assay in which the cyclic-AU~ dependent protein
kinase is used to bind the labelled cyclic-~i~ in the
presence of the unknown cyclic-~!P. The radioactivity
of the 'bound' fraction is a measure of the cyclic-l!..l.P
in the unknown sample ( Gilman: 1970; Walton and ·J.arren:
1970 and Brown et al.: 1971). Another method is to use
specific cyclic-AN~ binding antibody. Cailla et al.
(1974) have found that succinylating the cyclic-AI/LPin
the 2'-hydroxyl position leads to a much improved
sensitivity. The detection limit for this immunoassay
is claimed to be 50 amol.
Cyclic-ALiP has also been determined by the activation
of protein kinase (Wastila et al.: 1971) for which (~_p32)
labelled ATP was used as the substrate.
ation of p32 into protein was measured.
Sutherland (1958) used the activation of
The incorpor-
Hall and
glycogen
phosphorylase as a measure of cyclic-AMP. The assay
Was later automated (Davoren and Sutherland: 1963).
Other methods involve the direct measurement
of cyclic-AI'~. This normally involves the use of
labelled ATP as a substrate for adenyl cyclase (for
example: Streeto and Reddy: 1967). Brooker (1972),
however, uses high pressure liquid chromatography to
separate cyclic-Ali~ from other components and determines
it on the basis of U.V. absorption in a special flow
cell.
The following requirements have been delineated
for the assay of cyclic-AMP (Johnson: 1972)
(i) The treatment of the sample with an excess of
cyclic-AMP phosphodiesterase should result in a nil
response.
(ii) The addition of known amounts of cyclic-Al;lJ>
to any test sample should give the expected increments
in the response par~Jeter.
(iii) The assay should not be responsive to impur-
ities in the sample, so its purification should not
effect the result of the assay.
A cyclic-Amp binding protein assay which meets
these requirements was used for this work. The procedure
followed was the saturation assay of Br-own et al. (1971).
This assay recommended itself because of its simplicity,
accuracy, economy and reliability.
It is simple because it is a one step assay and the
techniques involved in setting it up are in essence
eLeraent ary (6'. B. ); 'although this is not to say that the
theoretical analysis is simple. Ekins et al. (1968)
have docunented an elaborate theory of saturation
analysis (including radioimmuno-assay) in whicc the
factors limiting sensitivity and precision were ~alysed.
'J:herecurrently expendable materials are cheap 8-"1Q.
therefore the method is economical. The wide use of
the techniques involved indicates their reliability.
Some features of the assay were examdried , Ilhe
adenylate cyclase activity of whole cell incubations of
red blood cells from three species were measured.
6.B. Materials and methods
The materials used in this chapter have been described
previously (2.B.a.).
6.B.a. Preparation of the cyclic-Amp binding protein
The binding protein was prepared from the bovine
adrenal cortex largely as described by Brown et al.
(1971). All steps were performed at 0-40C. Frozen
adrenal glands were thawed. The cortices were removed,
chopped and homogenised with 1.5 volumes of ice-cold
Littlefield's medium (Littlefield et al.: 1957) in a
blender (Attomixer) at full speed for 1 minute. The
homogenate was centrifuged for 5 minutes at 2,000 x g.
The supernatant was then centrifuged at 5,000 x g for
15 minutes. '.rheresultant '5,000 x g supernatant' was
stored frozen in 1 ml portions. The samples were thawed
and diluted as required (g.D.a.).
The 5,000 x g supernatant was frequently contamin-
ated heavily with yellow lipid. When this was the case
the supernatant was sldmr:ledbefore it was alio_uoted for
storing. ~hen necessary a 10,000 x g centrifugation
was used to bring the lipid to the surface so that it
could be removed.
6.B.b. The assay of cyclic-AMP
An aliquot of diluted 5,000 x g supernatant (6.B.a.,
6.D.a,) was incubated with the aamp.Le with an unknown
quantity of cyclic-AliIPand a standard am01L.'1tof radio-
actively labelled cyclic-AMP. The cyclic-AMP binds to
the protein. The incubation time was sufficient for
the system to reach equilibrium. All unbound cyclic-Al\1P
was removed by the addition of coated charcoal (6.E.b.)
and centrifugation in a bench centrifuge at full speed
for 3 minutes. An aliquot of the supernatrult (bound
fraction) was counted in a liquid scintillation counter
(2.B.m.). The degree of isotopic dilution is a ~easure
of the unknown cyclic-AIdP (6.C.). The procedure for
the assay is shown in table 6.1;-
Table 6.1
The Assay of Cyclic-~ciP
Temperature 0-40C.
Toa plastic centrifuge tube add:100jJl dilution bufferl
50}Jlunknown sample or standard containing 0-15pmol cyclic-AfuJ?
50}Jl (8-H3) cyclic-AMP (60n11,8nCi)2
100~1 diluted binding protein 5,000 x g supernatant
Mix and leave for go minutes or more.
Add lOOfl freshly mixed charcoal suspension4•
Mix thoroughly (Whirlimixer) and centrifuge.
Remove 100~1 aliquot from the supernatant for determinati~
o.fthe radioacti vity in the bound fraction and add to 4ml
of scintillation fluid in a counting vial.5
1) 50mM Tris.HOl pH 7.4 with 8mM theophylline and 6mM
2-mercaptoethanol.
2) The tracer is made up in dilution buffer.
3) The binding protein is diluted in dilution buffer (~.n~
4) Suspension of Ig Norit GSX charcoal in a 2';~soLut i cn
of B.S.A. in dilution buffer.
5} Toluene: 2-EE: PPO: POPOP (2.B.m.).
6'.B.c. Assay controls
'I'he total counts were determined by addi.ng£'.11 the
solutions except the charcoal suspension to a tube ond
J:lakingup the volume of charcoal with dilution buffer.
This results in a slight underestimate of the total
counts because of the volume of the charcoal suspended
in the other tubes. This was determined by adding 109
of charcoal to 100 ml of 2% B.S.A. in dilution buffer.
The volune of the suspension was 106ml, so the charcoal
contributes 5. 6j~ of the volume of the charcoal suspension.
The contribution of the charcoal to the volw~e of the
experi~ental tubes was therefore 1.4%. This was the
factor by which the total counts control under-est Lma'ted
the actual total count relative to the other tubes. As
this affected all results in the same way ana did not
affect the determination of the cyclic-AMP it was ignored.
A control in which no binding protein was added to
the control tube and in which the volume was I:'J.adeup
with dilution buffer gave the proportion of radioactivity
not absorbed by the charcoal. Where there has been an
exchange of tritium between the cyclic-AMP and the
solvent this would be expected to increase this control
count. The cyclic-AMP must also be distributed between
the charcoal and the solvent. The amount of cyclic-Al,lP
remaining in the solvent was found to vary with the
co~position of the solvent. The count rate for the
control was independent of added cyclic-AMP up to 100nM
concentration and it was proportional to the concentration
of the tracer cyclic-~~ up to lOOw~also. Ethanol at
concentrations as low as 4 to 5~~was found to increase
the count rate by 50%. Sodium chloride did not affect
the count rate for lOnM tracer (up to 1 AINaCl tested).
The necessity for controls because of variations in
the constituents of the assay sample which might affect
the binding protein and the charcoal and therefore alter
not only the zero reading but also the shape of the
standard curve has been emphasised by Albano et al.
(1974). The assays for cyclic-AMP in this chapter had
zero cyclic-AMP controls but none for variations in the
shape of the standard curve.
6. C. Theory
6. C.a. i.rherio st convenient linear representation of
results for a standard response curve is that of Hales
and l{fu~dle(1963). In the assay for insulin using the
insulin arrt i.-cbody they derived the following relation-
ship on the ba3is of the isotope dilution of the anti-
body precipitate by the sample or standard insulin:
Co i
= + 1 (1)
Ci io
i is the concentration of sample or standar~; io the
concentration of tracer. Co is the COQ~t rate of the
precipitate (bound fraction) when no sample or standard
is present and C. is the count rate when the s~ple
3.
concentration is i.
The equation only holds if the anti-body is fully
saturated in the presence of tracer alone. ~his is
seldom the case and does not happen in this assay. The
relationship was extended by dunderwald et al. (1974)
to take account of the degree of saturation of the
binding protein in the assay of cyclic-~I~.
has the form (following the notation above):
Co (io)Bd (i )-::: -+ 1
C i (i + i 0 ) Bd i 0
where (io)Bd and (i + iO)Bd correspond to the concen-
trations of the bound species in the presence of tracer
alone and tracer and aanpLe respectively. ilhenthe
tracer nearly saturates the binding protein the curve
does not deviate significantly from a straight line.
6.C.b. The accuracy of the assay has been described by
Ekins et al. (1968) in terms of the precision and the
The equation
(2)
sensitivity as defined below;
(i) ~recision 6p = AR
dR/op
(ii) Sensitivity 8p' = AR I
~R/Op p=O
where ~R is the error in the response parameter; Ap is
Ithe error in measurement of the substance P being assayec
and oR/~p is the gradient of the response curve.
(3)
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Theoretically the assay can only be opturdsed for
one concentration of cyclic-A1U', that is, one point on
the response curve is more :lrecisely def Lned than all
the other pOints. Neighbouring pOints will be less
precise but never-the-Iess still accurate. The further
a pOint is froD the most precise reeion of the curve
the less precise it wil~_ be .:rhe r-ange of satisfe.ctory
precision depends on the error in the respor-se par~~eter
and the gradient of the response curve (equation 3).
6.C.c. The experimental errors are likely to be the limit-
ine factor in the optimisation of t~e assay. The
relative error in the result of the assay, AR, has two
basic components, namely the relative experir:J.ental
error ana the systematic error which is prir;:a:rilythe
scintillation countin~ error. These may be represented
as ( and ~n/N resfectively where N is the cour-tfor the
sample and (In= N:cl.
The experimental error arises mainly from the
pipetting of the various solutions in the assay, which
involves six steps, and the preparation of the st ancar-d
solutions. As piston pipettes were used the approximate
error in each of these steps was 0.01 (Ellis: 1973) ~~d
the conbined error is approximately 0.03.
The error in the response parameter ~R is given by:
sa ~ (E2 + ~t (5)
If the counting error is less than ( then:
E: < ~R < 2t E:. (6)
This will be so if N ) 1110. This is an experimental
condition that can be'easily met. If
form of equation is used involving 0o
Co and Cx are subject to these errors
error is increased so that
J..
22£, < ~R < 2(;
the linearised
lOx where both
then the total
( 7)
6 .D. Hesul ts
6.D.a. The dilution of the binding protein
Using the standard procedure (table6.1) with the
dilution buffer replacing the sample, the tritiated
cyclic-AlvlPbound by six serial dilutions of the 5,000 x g
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eupe r'riat rrt (1/2, 1/4,1/8,1/16,1/32 and 1/64) was
measured. The results are shown in fig. 6.1. The
dilution required in the assay is that which e;ives
approximately 30-40% binding of the tracer. The
appropriate dilution was selected by referring to the
dilution curve.
6.D.b. Cyclic-AMP standard curve
The assay was carried out as described in section
6' • B. b , , .A stock solution of J!)"ugml-1 cyclic-Ahll'(30.4#111)
was diluted 1 in 50.7 to give a 600nM solution. '£his vias
then diluted to give the concentrations used in the
preparation of the standard curve, n~1ely, 2, 5, 10, 15,
25, 30, 50, 75, and 100nM. The assay volume was 0.3ml
so the amounts of cyclic-AEP used were 0.7 to 30 pmol.
The standard curve is shown in figure 6'.2 in which
the results are plotted in four of the forms commonly
used for saturation analysis data.
6.E. Method for the assay of adenylat~ cyclase
The enzyme was assayed in turkey, rat and human
erythrocytes. The cells and stroma were prepared as
described in sections 2.B.c. and 2.B.d •• The cells were
washed and resuspended in glucose supplemented saline
(154mM WiCl plus l/20th volume of 5.4% D-glucose) •
The cells or stroma were incubated in a small
plastic test-tube with the solutions ahown .i.n table 6.2.
The test-tube had to be capable of withstanding boiling
and centrifuging 'at full speed in a bench centrifuge.
Table '6.2
Incubation for the Assay of Adenylate Cyclase
Temperature: 37°C.
Contents of the incubation medium:
0.35 ml 50 mM 'rris.HCI pH 7.4 containing 2mM ATP
3mM MgS04
8m!l1theophylline
O.lOml 650mM NaCl containing 1/20thvol. 5.4% glucose
0.05ml lmhladrenalin or I M NaF
0.10 ml blood cells in a 50% suspension
Figure 6.1
A Dilution Curve for the 5,000 x g SUDernatant
Percentage of
total counts
in the bound
fraction.
The assay was as described in
the text (6.B.b.) except that
serial dilutions of the binding
protein were used and the
sample was replaced with dilution
buffer.
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Figure 6.2
Standard Response Curves for the Assay of Cyclic-AMP
a) C /e, as defined in q.C.a.;o 1.
free and bound fractions; c) r,
bound and d) Rblf, the ratio of bound and free fractions
are each plotted against the concentration of cyclic-~~.
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The reaction was started by the addition of the
'enzym~ or adrenaline The reaction was terminated either
by putting the tube in a bath of boiling water for 3
minutes or by rapidly cooling in an ice-salt bath and
centrifuging at oOe to separate the cells from the
suspending medium. The supernatant was drawn off and
the cells resuspended in the same volume of cold saline
as the supernatant. The supernatant and resuspended
cells were put in a bath of boiling water for 3 minutes.
These procedures were carried out as quickly as possible.
The denatured protein was removed by centrifugation and
the supernatants were then assayed for cyclic-AMP. This
procedure was taken from the work of Davoren and
Sutherland (1963).
6.F. Results
6.P.a. Adenylate cyclase in turkey erythrocytes
In an initial tes1:for the activity of adenylate cyclase
in turkey erythrocytes the stroma were prepared (as
described in sections 2.B.c. and 2.B.d.). The time
course of the reaction was ten minutes and the enzyme
was activated by 0.083MNaF. The activity of the enzyme
was 380±150 pmol cyclic-AillPformed/h/mg protein. The
protein concentration was estimated by the method of
Lowry et al. (1951), see section 2.B.e. The large error
was due to the heterogeneity of the suspension used for
the assay.
The production and release of cyclic-AMP by turkey
erythrocytes was measured over a period of 30 minutes.
The results are shown in figure 6.3. The packed volume
of cells used was 0.05ml and the incubations were set
up as described in section 6.E•• The activating agent
was 0.083 mM adrenaline
6.P.b. Adenylate cyclase activity in rat red blood cells
Haemopoiesis was stimulated in rats by bleeding.
Blood samples with approximately 20% reticulocytes
were assayed for adenylate cyclase activi ty alongside
normal blood samples in order to compare the activities
of the respective enzymes. The results of this together
with the assay details are shown in table 6.3.
Figure 6.3
Time Course for the Formation and Release of
Cyclic-AI/CPby 'l'urkeyErythrocytes
Cyclic-AMP
nmol/50}Jl cells
1.5
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o
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KEY:
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o Cyclic-AMP in the
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~ Cyclic-lW~ released
from the cells
The assay was as
described in the
text ('6. F. a. ) .
Table 6.3
Assay for Adenylate Cyclase Activity in Rat Red Cells
The assay procedure was as described in table 6.2.
Blood samples 1 and 2 were assayed as whole blood.
Samples 3 and 4 were washed red cells.
Sample Reticulocyte Cyclic-ALIP pmol/50pl cells Activity
~ o min. 10 min. nmol/ml/h
1 1 147 219 8.6
2 20 260 360 12.0
3 1 100 204 11.4
4 18 142 396 27.7
It is clear that the major activity of adenylate
cyclase is to be found in the high reticulocyte-blood.
6.F.c. Adenylate cyclase activity in human red blood cells
One day old samples from two patients at the
Coventry and Warwick Hospital who were suffering from
macrocytic anaemia and a third patient suffering from
ulcerative colitis were assayed for adenylate cyclase
activity using an 8% suspension of the cells.
i) Assay of 10% reticulocyte (ulcerative colitis) and
normal human blood.
The assay was as described in table 6.2 with an
incubation time of 10 minutes and 0.083mM adrenalin
added to activate the adenylate cyclase. There was no
cyclic-AMP produced in the incubation as determined by
the normal cyclic-AMP assay (6.B.b.).
ii) Assay of 18 and 20~ reticulocyte (macrocytic anaemia)
and normal blood.
Both the washed blood cells and stroma (section 2.B.c
and 2.B.d.) were assayed in the presence and absence of
activators. Both adrenalin (0.083mM) and NsF (0.083M)
were used to activate the enzyme.
It was noticed that in the presence of activators
cyclic-AMP appeared to be formed. However, the no-enzyme
controls in which there was activator also showed the
same deviation from the normal count rate. The net
result therefore was that no cyclic-AMP was deteeted.
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All the assays on h~~an red blood cells were
carried out in duplicate. The average va1.uefor Co ICi
for sample i) was 0.99±O.03 and for sample ii) O.94±0.16.
The larger 'error in the case of 2runple ii) was due to
the variations shown by the control r-esuLt e. The
detection limit of this assay waG about Ipmol.
6.G. Discussion
'.rheassay for cyclic-AI·J:Pdescribed by Brown et al.
(1971) was used to measure the adenylate cyclase·-:a.ot1vity
in the redblood cells of three species. ~he assay was
not used under optimal concitions for sensitivity. I'his
would only have been desirable in the assay of the enzyme
frow human red cells.
The tritiated cyclic-~dP was obtained as a solution
in 50% ethanol and was diluted for use. This meant that
there was a small amount of ethanol in the assay. This
Idid not appear to unduly affect the results (c.f. chapter
8.D.b.). It also meant that any tritium exchanged
between the cyclic-AMP and the solvent would be carried
over into the assay. This contributed to the count
rate observed for the control in which there was no
binding protein added. This control deterffiinesthe
radioactivity not absorbed by the charcoal. The count
rate was found to be proportional to the amount of
H3-cyclic-~ill?added and was not normally affected by
the addition of unlabelled cyclic-A1~ or salts, though
it increased with the concentration of ethanol. Care
had to be exercised in the use of charcoal as it was
easy to disturb the sedimented charcoal when samplinG
for the counting procedure.
A labell~d cyclic-AMP solution was chromatographed
after two months to check whether it was still chemically
pure. The chromatographic system was that described in
section 4.B.b. using the first solvent only. The
cyclic-AMP had an Rf of 0.57 and AMP an Rf of 0.76.
Nine percent of the counts were found associated with
the AMP spot, the remainder were located in the cyclic-
AIJ:P spot.
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The assay results for the turkey erythrocytes show
a similar activity of adenylate cyclase to those assayed by
~ye and Sutherland (1966). The time course and release
of cyclic-AMP are similar to those observed for pigeon
erythrocytes by Davoren and Sutherland (1963) except
that the concentration of the released cyclic-AMP is
much lower in this case. This may be due to the differ-
ence in concentration of blood cells in the two assays.
The erythrocytes contributed 50% of the volume of Davoren'f
incubation medium whereas for these results the percentage
was 8. 31'~.
Gauger et al. (1973) assaying rat red blood cells
concluded that the activity of the adenylate cyclase was
localised in the reticulocytes. The results here show
that the activity is much greater in the reticulocytes.
and perhaps young erythrocytes also. than in a normal
blood sample.
Sheppard and Burghardt (1969) who were the first
to show the activity of adenylate cyclase in rat erythrocyte
ghosts also assayed the enzyme in human erythrocyte
ghosts. They found that there was a very slight activity
in the red cell preparation but considered that it may
have been due to impurities. Adenylate cyclase has been
found in human white blood cells (StoIc: 1973;
Constantopoulos and Najjar: 1973) and also in platelets
(Murakami et al.: 1971).
The possibility of the enzyme being found in samples
of red blood cells with a high reticulocyte count was
tested.
The blood with the high reticulocyte count from a
person Buffering from ulcerative colitis may be compared
with the rat blood in which a high reticulocyte count
had been caused by bleeding. Ulcerative colitis is
characterised by mucosal inflamation of the rectum and
colon and is usually accompanied by a discharge of blood
and mucus with the stool. This results in stress
erythropoiesis like that of the rat induced by bleeding.
The reticulocytes formed in the case of macrocytic
anaemia, however, are larger and have a different nuclear
structure from the normal (normoblastic) reticulocyte.
The:r arise from an alternative differentiation pathway,
megaloblastic naemo poi esa e, ~atr.E"rthan the no rrne.L path-
way, normoblastic he..emopo::'esis.
No adenylate cyclase activity was:detected in either
cell type under the conditions of'cne assaJ.
The lack of adenylate cyclase activity in mature
erythrocytes in human and rat blood would appear to
indicate that cyclic-AMP has no function in such cel~s.
Its presence in rat reticulocytes, however, means that
this conclusion cannot be taken to include the developing
red cell. The formation of red cells is triggered by
the hormone erythropoietin, and it may well be that the
function of this hormone requires the action of
adenylate cyclase.
CHAPTER 7
PARTIAL PURIFICATION OF THE CYCLIC-AMP BINDING PROThIN
7.A. Introduction
The occurrence of non-linear binding curves (section
8.D.) for the binding of cyclic-AMP to the 5,000 x g
supernatant indicated that the binding was more compli~
ca.ted than a 1:1 complex formation between the cyclic-
~UP and the protein kinase.
The non-linear nature of the binding curves may be
caused by the presence of more than one type of binding
protein characterised by different dissociation constants
for the binding process. Other plausible explanations are
tha'iithe dissociation of the regulatory subuna t from the
catalytic subunit changes the affinity of the receptor
site for cyclic-AMP or that there is some degree of
cooper~tivity in the binding process.
The 5,000 x g supernatant was fractionated and the
cyclic-~JP binding protein partially purified in order
to investigate the origin of the non-linear binding
curves. The binding studies are dealt with separately
in chapt er ~.
r.B. Materials and methods
General comments relating to the techniques used
in sections 7.C.a.- 7.0.d are to be found in chapter 2
sections B.h.- B.j .•
7,.B. a Protein kinase assay
The protein kinase assay used in section 7.0.c. was
a development of the assay of Kuo et al.' (1971). The
solutions used are shown in table 7.1. They were all
made up in 67m1~ sodium acetate buffer pH 6.0. The
•enzyme was assayed by pipetting 50pl of solutions 1),
2) and 3) or 4) into a small plastic tube. The contents
were brought to the reaction temperature (3000) and
50pl of enzyme solution were added. The contents were
mixed and left at 30°0 in a shaking water bath. The
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Table 7.1
polutions used in the assay of protein kinase
1) O.8ng/ml histone and 40mK magn.esi.um ac et a.te in buffer
2) 5JJM, (t _p32 )ATP: lCi/mmol in buffer
3) buffer (67mIfi sodium acetate buffer pH 6.0)
4) 2f1:ii cyclic-AMP in buffer
5) stop mixture of 5~~TCA and O.25:i~ sodium tungstate
pH2.0
reaction was stopped by removing a 50~1 aliquot of the
incubation mixture and placing it on a filter pad (1.5cm2,
Whatman 3I',il\1 filter paper) which was pl.aced immediately
into a beaker containing solution 5). This follows the
filter paper disc technique of Bollum (1959 and 1966).
The time at which the reaction was stopped was taken
as the moment when the filter paper disc was placed. in
the stop mixture. Sodium tungstate was included in the
stop mixture as polylysine (a model compound for histone)
is not completely precipitated by TCA alone but has been
shown to be insoluble in tungstic acid (Gardener et al.:
1962). The amount of'stop mixture used per filter pad
was lOml.
The advantage of this technique was that it enabled
a batch of sau1ples to be treated together rather then the
individual washes required for the protein precipitate.
in the Kuo method. The filter pads were washed tV/ice in
each of the following solvents: stop mixture, 95% ethanol,
and ether. The pads were stirred in each solvent (5rnl
per pad) to ensure that they remained separate. The
wash solution was then decanted off and after the final
wash the pads vtex:« dried in a stream of air. The pads
were then placed in scintillation vials with 4ml of
toluene: PPO: POPOP and counted in a Packard 2450 (2.B.m.)
on preset settings for determining p32 ( efficiency
estimated to be 37~). A total count was obtained by
counting a filter pad that had had 50~1 of incubation
mixture placed on it and had then been allowed to dry
in air.
I This teclmique depended upon the precipitated
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protein becoming enmeshed in the paper but the smaller
molecules were free to diffuse out of the paper during
the wash procedures. Nost of the radioactivity was
removed in the first two washes.
Although the technique allowed a number of saI1ples
to be treated at once, care had to be taken to ensure
that the filter papers were not left in the stop mixture
too long otherwise they began to fray. It was found
that 50 reaction tubes could be han61ed in less than 20
minutes. The fraying did not become serious until
after 30 minutes had passed.
7.B.b. Sucrose density gradient centrifugation
Linear sucrose density gradients were prepared
using a perspex block gradient mixer with equal bore
chambers. The gradient volume was 5ml so each chamber
was filled with 2.501 of 20j~ and 51~sucros e :-:.adeup in
the standard dilution buffer· (table 6.1). The centrifuge
tubes were filled by gravity feed from the gradient
mixer. The outlet tap was partially closed to limit the
flow rate into the tube. A 0.4ml sample of protein
was then added to the density gradient.
The gradients were centrifuged in a Beckman L-2
ultracentrifuge using an SN 50L rotor. The head was
centrifuged at its maximum rating (reduced througc ~sage
to 38,000 rpm) for 18 hours, following the procedure of
IJartin and Ames (1961).
7.B.c. Polyacrylamide gel isoelectric focusing
The isoelectric focusing was carried out using an
LKB 2117 multiphor. The gel was prepared by J. Wood*.
Two samples were applied to the anodal end of the gel
2on a piece of filter paper 1 x 1.5cm. The instrument
was set initially to a voltage of 1,000V and 30mA. The
final settings were 1,100V and 4mA. The two s~~ples
were removed and then one was stained with Coomassie
blue for 20 minutes. Excess stain was removed by
immersing the gel in a water, ethanol and acetic acid
mixture (8:3:1 by volume) for 15 minutes at 60°0. The
other gel was soaked for 2 hours in a solution of
* ·Av'researchstudent in Molecular Sciences Dept.
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H3-cyclic-AMP (60nM in dilution buffer: table 6.1). The
gel was then washed twice in dilutioh buffer by immersing
it in the buffer for ~bout two hours. It was then
sectioned into 24 bands and these were mashed ane counted
using the toluene: 2-EE: PPO: POFOP scintillation fluid.
7.C. Results
7.C.a. Ammonium sulphate fractionation
AmmoniuIllsulphate fractionations were carried out
on several preparations of the 5,000 x g supernatant
(B.B.a.). Lost of the cyclic-AMP binding activity was
precipitated in the range of 20-60% aramonium sulphate
saturation (table 7.2).
Table 7 .2
Ammona.um sulnhate fractionation of the
5,000 x g supernatant
Fraction H.elative ,l<'ractionRelative Fraction Helative* * *A(%) activity B(%) activity C(%) activity
0 - 20 5 o - 15 12 o - 15 12
15 - 30 10 15 - 35 920 - 40 79 30 - 45 38 35 - 50 50
40 - 60 16 45 - 65 40 50 - 65 29
* The relative activity was determined by plotting B
against B/F (see section 8.C. and 8.D.b.) for each
fraction. '.rhefigures represent the percentage of total
binding sites for each fraction.
Binding studies indicated that the protein
precipitated at about 20% saturation and at 40 - 50%
saturation had a Kd of 3 - 4 nM. The protein precipitated
in between these two had a higher dissociation constant.
(These results are shown in section 8.D.b. and are
discussed there.)
The dilution curves (6.D.a.) are sho~n in figure
7.1 for fractionation C above' (table 7.2). The dilution
curves show that the amrJonium sulphate fractionation
enabled an increase in the cyclic-ALU> binding specific
activity for fractions above 15% saturation and below
Figure '7.1
Cyclic-Nifr bindine dilution curves for ammonium sulphate
fractions of the 5,000 x g supernatant
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7.C.b. Cellulose phosphate chromatography
A cellulose phosphate column was used to fraction-
ate the binding proteins. The column was used initially
at .pH7.4 but after a gel-isoelectric focusing experiment
I
(7.C.f.) the pH was reduced to 5.1. The fractions
eluted from both columns were determined for cyclic-
AlIIPbinding activity at pH7.4.
The elution profiles are shown in figures 7.2
and 7.3. The conditions used in the chromatography are
described in the corresponding legends.
In both figures it is seen that the cyclic-A!.:P
binding activity was partially resolved into two peaks.
In the first column labelled cyclic-ru.lPwas added to
the 5,000 x g supernatant before adding it to the column.
The quantitiy of cyclic-AII1Padded was insufficient to
saturate the binding protein. The radioactivity of the
fractions was measured before and after the aduition of
coated charcoal. 'rhedifference between t hes.eC01.l.."1ts
represents the free cyclic-~dP shown in fi~:e 7.2.
The srunple for the second column was an aliquot
of the 5,000 x g supernatant. The binding activity of
the fractions was measured by taking aliquots of 0.5ul
from each fraction. They were brought to pH 7.4 by
adding 0.05ml of 0.08M Tris base, and O.lL1l of 60nliI
H3-cYClic-~~ was added. After equilibrating at OOC,
O.lml of the charcoal suspension was added, the contents
of the tube were thoroughly mixed and centrifuged. The
radioactivity of the supernatant was measured in the
usual manner.
The binding proteins were separated as in the
previous column into two peaks of binding activity. A
third minor binding peak was also noticed.
7.0.c. DEAE-cellulose column chromatography
The use of DEAE-cell~lose in the purification of
bovine adrenal cortex cyclic-AMP dependent protein kinase
has been reported by Gill and Garren (1970).
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Figure 7 .3
Cellulose phosphate column pH 5.1
The elution profile for a 10~1 sample of the 5,000 x g super-
natant added to a colunm of cellulose phosphate (3 x 12cm)
I
equilibrated with O.025M sodium acetate buffer pH 5.1 containing
6mM 2-mercaptoethanol and eluted with the same buffer. Addition
of sodium chloride in concentration steps (50mM, lOOmM and
200mm) was made to elute any further binding activity.
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li'ie:_""Ures7,.4 - 7,.6 show the elution profiles of the
5,000 x g supernatant and two ammonium sulphate fractions
from the 5,000 x g supernatant. Each sanp'Lewas
dialyscd over night against 101 of the equilibration
buffer for the c oLunn , The dialysed sarapLe was tl:en
centrifuged at 10,000 x g for 30 minutes before putting
on the column.
For, the first two coLumn s (figs. 7.4 and 7.5) only
the cyclic-AMP binding activity was measured. For the
third column both cyclic-~;~ binding activity and protein
kinase activity were measured. The conditions used in
each case for the elution and assay for activity are
described in the respective legends.
I (figure 7.4) DEAE-cellulose chromatography of the
5,000 x g supernatant.
l'heI cyclic-AMP binding activity was divided into two
major peaks (A and B) presumably corresponding to Gill
and Garren's cyclic-~l~ dependent protein kinase and the
cyclic-Ah~ receptor protein (Gill and Garren: 1970).
However, there appeared to be cyclic-Ali~ bd.nd i.ng'activity
in other peaks (C,andD) not detected by Gill and Garren.
Their partial purification of the protein kinase and
cyclic-~1P binding activities by ammonium sulphate
frac.tionation (0 - 54~~) and calcium phosphate gel
cr~omatography may have removed these bands.
Pooled fractions from this column were used in the
sucrose density gradient work (':/.C d!')and in the study
on the effects of cyclic-GMP on the binding of cyclic-
AliIP (8.F.a.)
II (figure 1.5) DEAE-cellulose chromatography of a 30 -
65% ruIDJoniumsulphate fraction.
The fractions eluted from the column were assayed for
cyclic-AMP binding activity at two concentrations of
cyclic-AMP, namely'lOnIv1and lOOnhI.
There were two major peaks of binding activity.
The first (A) was detected using lOOnM cyclic-AMP and
was therefore thought to be a more weakly binding protein
than the second peak (B) which was more apparent when
10nM cyclic-AMP was used. The fractions comprisinG the
IFigure 1.4
DEAE-cellulose column I
Elution profile for 20rnl of the 5,000 x g supernatant dialysed
against 20w,1 Tris .HCl pH 7.3 and added to a 2 x 23cm column of
DEAE-cellulose equilibrated with 20mllilTris.HCl pH 7.3 containing
6mM 2-mercaptoethanol and eluted with a linear gradient of NaCl
o - O.25M followed by O.4M NaCl all in the equilibration buffer.
Bin<iing activity was measured by removing O.lrnl aliquots from
the fractions and assaying as in section Q.B.b ••
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Figure 7,.5
DEAE-cellulose colULm li
Elution profile of 50ml dialysed 30-65% ammonium sulphate fraction
from a 2 x 23cm DEAB-cellulose column equilibrated with 20mM Tris.
HCl pH 7.3 containing 6mln 2-mercaptoethanol and
eluted with two linear sodium chloride gradients
(0-0.25M and 0.25-0.5111). Assay as in 6.B. b •.
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two peaks were pooled and.frozen. Samples were thawed
for determination of the dissociation constants of the
two proteins (B.D.c.) and subsequently wers used in a
study on the effect of other column fractions on the
binding of cyclic-AMP (8. E.c.)•
TIl (figure 7.6) DBAL-cellulo~e chrocatogropny of a 0 -
50% arruaorii.umsulphate fraction.
The f'r-act aona from the coLumn were assayec for cyclic-
Al.iFbinding activity using a 100n1,~soLuti on of 53_
cyclic-Ald? (ASS2YS were also carried out using 10nlrI
and IjJIIlH3-cyclic-AlllPbut unlike the previous column
the elution pattern was not changed.) The fractions
were also assayed for protein kinase activity in the
absence and in the presence of O.67,.uMcyclic-AMP. The
results obtained are similar to those of Gill e~d Garren
(1970) except for the high peak of cyclic-AMP dependent
protein kinase activity which just precedes t~e najor
cyclic-AMP binding peak. The active fractions from this
colwrll were uSed on a Sephadex column so as to distinguish
betwe en the peaks on the basis of molecular weieht
(7.C.d.). Dilution curves were constructed for the
cyclic-ALI} binding activity and protein kinase activity
of the active fractions (figure 7.7).
A swrunary of the results obtained from these columns
is given in table 7.3.
7.C.d. Sephadex G-IOO gel filtration
Sephadex G-IOO was chosen for use as the bovine
adrenal cortex protein kinases have molecular weights
of about 145,000 and 60,500 (Gill and Garren: 1971).
This meant that the protein kinase was near the exclusion
limit for the gel and the length of time the proteins
were on the column was minimised.
A column 4.5 x 55cm was prepared using gel swollen
in 50mM Tris.HOl pH 7.4 containing O.lM NaCl and 6mliI
2-mercaptoethanol. The gel was protected by a layer of
Sephadex G-25.
The DEAE-cellulose column ]I fractions containing
protein kinase and cyclic-AlilPbinding activity were
pooled and reduced in volume by precipitating the protein
Figure 7.6
DEAE-ce11u1ose column TIl
11ution profile of 400ml dialysed 0-50~'o ammonium sUlphate fraction
Ifrom a 4. x 60cm DEAE-cellulose column equilibrated with 20mM Tris
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Table 7.3
Purification of the cyclic-AMP binding protein by
DEAE-cellulose chromatography
I Fraction Volume Protein C-AJ:,lPbound C-AMP bound*
ml mg/ml cpm (lOnM) cpm (20nM)
A. 14_5 4.2 500 - 564
, ' 2.8 4850B 5.7 3400
C 8.5 1.7 2900 2520
D 5.8 1.1 2300 1290
* the second assay using 20nM cyclic-AMP was performed
after leaving the fractions for 1 week.
:0: Fraction Volume Protein Kd Comments
ml mg,lml n.M
A 49 8.9 1.4 Expected larger valuefor Kd.
B 55 7.0 14
Fraction Volume Binding activity Protein kinase activity
ml dil!! r dil!! +c-Al1P -c-AlJP
A 170 1 in 4 0.07 1 650 650
B 195 1 in 2 0.59 1 in 4 2850 6500
C 160 1 0.40 1 in 2 1250 2350
ID:
The volumes and protein concentrations in part I relate
to the fractions after treatment with Aquacide to reduce
the volumes. The normal cyclic-AhIT binding ass~y was
used with the concentrations of tracer as shown in the
table (see section 6.B.b. for the assay). In part ]I of
the table the cyclic-AMP binding activity and the protein
kinase activity are given for the dilution which gave the
maximum activity in each case: r is the fraction of tracer
bound and the protein kinase activity was measured in the
presence and absence of 0.67fM cyclic-AMP as described in
section 7.B.a ••
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with a ° - 60% saturation ammonium sulphate cut at pH 6.0.
The precipitate was resuspended in about 30ml of the
column equilibration buffer and centrifuged at 30,000 rpm
using a 50Ti head in the Beckman L-2 ultracentrifuge.
The clarified solution was applied to the colULm.
Bvery third fraction was assayed for both cyclic-~~
binding activity and prctein kinase activity (as described
in sections 6.B.b. and 7.B.a. respectively). Small peaks
of both activities were present (figure 7.8). However,
assays carried out the following day on the fractions
containing the peaks were not able to detect either
activity.
It was concluded that as a result of the use of
the Sephadex column the enzyme became unstable. It was
noted that other workers using Sephadex gels to purify
protein kinases use 10% glycerol to stabilise the enz~.
7.0.e. Sucrose density gradient centrifugation
Samples taken from the DEAE-cellulose colwJn I
(7.0.c.) were applied to sucrose gradients and centri-
fuged as described in section 7.B.b •• The sedimentation
pattern is shown in figure 7.9. The gradients were
sampled by inserting a long needle down the tube and
withdrawing the contents using a peristaltic pump at
low speed. The fractions were measured by counting the
drops. Equal aliqots from each fraction were assayed
for cyclic-AMP binding activity.
A control in which increasing concentrations of
sucrose were added to three of the DEAE-cellulose
fractions showed that sucrose did not affect the binding
of cyclic-AMP to the protein at concentrations below
O.2M. Above this concentration the binding is decreased.
The molarity of the sucrose in the gradient was between
O.146M (5~) and 0.585M (20~). The samples taken from
the gradients were all diluted 1 in 4 in the assay so
',. ·the concentration of sucrose was less than 0.2M in every
assay.
7.C.f. Polyacrylamide gel isoelectric focusing
A sample taken from the pH 7.4 cellulose phosphate
column with high cyclic-AMP binding activity was applied
·f
Figure 7.8
Sephadex G-100 gel filtration
The elution profile of cyclic-A11P binding acti vi ty and protein
kinase activity from a 4.5 x 55cm Sephadex G-100 column. The
details are given in the text (~.C.d.). Elution was with the
equilibration buffer. The Kav values were calculated by using
a standard equation (Reiland: 1971). The void voLuma was obtained
using blue dextran. K
av
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Sucrose density gradient centrifugation
(For details see J.C.e.)
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Figure 1.10
Polyacrylamide gel isoelectric focusing
(For details see 7 .C.f.)
1) Impression of gel stained with Coomassie blue.
2) H3-cyclic-AlJ1Pbound to protein in the gel.
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·to the polyacrylamide gel (seesections 7.B.c. and 7 .C.b.).
Figure 7.10 shows the migration pattern at' the proteins
in the sample and the position of the' binding activity.
The pH range across the gel was pH 3.5 to pH 9.0. The
cyclic-AliI?binding region was in the low pH region
corresponding to pH 4.0 - 4.5. Gill and Garren (1971)
found that the isoelectric pOint of the protein kinases
from the bovine adrenal cortex was pH 4.75.
7.D. Discussion
The protein kinase assay was a combination of a
standard protein kinase ass~y incubation (Kuo et al.
1971) and a batch method for preparing the assay samples
for counting. This enabled the assay of large numbers
of samples with good reproducibility.
A number of methods were used to obtain partial
,
purifications of the cyclic-~JP binding protein and the
protein kin~se. These.are discussed separately below.
(i) Ammonium sulphate fractionation A consistent
finding in the ammonium sulphate fractionations was the
presence of two protein fractions containing bind~g
proteins with low dissociation constants (Kd < 5) and
one with a higher dissociation constant (Kd > 20) • The
two protein fractions containing the proteins with low
dissociation constants precipitated at about 20,0 and
40 - 50% ammonium sulphate saturation. The protein
with the higher dissociation constant precipitated
between these two.
(ii) Cellulose phosphate column chromatography Two
peaks of cyclic-AMP binding activity were eluted from
cellulose phosphate colwims at pH 7.4 and pH 5.1 when
a sample of the 5,000 x g supernatant was applied to
the column. The two peaks, which probably correspond
with the protein kinase holo-enzyme and the cyclic-~dF
binding regulatory subunit, were not well resolved.
So further characterisation was not attempted.
(iii) DEAE-cellulose column chromatography The results
from these columns has been discussed a little in the
relevant text. The first column described followed the
pattern of Gill and Garren's (1970). The differences
between the results of the two columns has been commented
on.
A 30 - 657~ rulli~oniumsulphate precipitated protein
fraction was added to the second column (JO. Two peaks
of cyclic-AMP binding activity were eluted from this
column. The first peak to be eluted was detected with
IOOnM cyclic-AMP, the second peak was more apparent
with IOnM cyclic-~'~. The implication appeared to be
that the second peak contained a protein with a low
dissociation constant for the binding of cyclic-AMP and
that the first peak contained a protein which bound
cyclic-AMP more weakly. This is the reverse of what
was actually found (a.D.c.) after the fractions had
been stored in a frozen state. This is discussed more in
the following chapter.
The third DhAE-cellulose column (]I) was used to
fractionate a 0 - 50~~ammonium au'Lpha't eprecipitated
protein fraction. The 'eluate was assayed for both
cyclic-~dP binding activity and protein kinase activity.
Two peaks of cyclic-~dP binding activity were eluted.
Cyclic-AMP independent protein kinase activity was
associated with the first peak. The pattern of protein
kinase activity around the second cyclic-~I~ bindine
fraction was rather more complicated. A peak of cyclic-
AMP dependent protein kinase activity just preceded
the peak of cyclic-AMP binding activity. Immediately
following the peak of binding activity was a peak of
cyclic-AMP independent protein kinase activity. The
peaks of activity were pooled as shown in figure 1.6.
The cyclic-AMP binding and protein kinase activities of
these pooled fractions was shown in figure 1.1. Both
of these activities are increased by dilution in the
case of fraction B and in the case of fraction C the
cyclic-AMP dependent protein kinase acti~ity is also
increased by dilution. A similar effect has been noticed
with the cyclic-AMP binding activity of the protein
precipitated between 35 and 50% saturation of ammonium
sulphate.
'-:'::_"z ~>;':':';';".~.8 pehaviour ~be dueto.,ome further equilibrium
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being imposed on the cyclic-~uP binding equilibrium and
controlling the amount of protein kinase holo-enzyme
available for activation. The possible reasons for this
are discussed further in the following chapter.
(iv) Sephadex G-IOO gel filtration The exclusion limit
for this gel prohibits its use to detect aggregates of
the protein kinase. The conditions under which the
column was used made the enzyme uns tabLe ,
(v) Sucrose density gradient centrifugation The
protein fractions from the D~AE-cellulose column I were
applied to sucrose gradients. The resulting sedimentation
pattern was similar to that obtained by Gill and Garren
(1911). Fraction A, however, in addition to a-peak
corresponding to Gill's 1S protein kinase holo-enzyme
also had a broad shou1der peaking in the 105 region.
The other fractions gave peaks in the region of 43 only.
The lOS peak may represent a dimeric form of the protein
kinase as found in bovi'ne brain (IJiYaInotoet al.: 1911).
A simple equation relating sedimentation coefficients, S,
to molecular weight • is
!~ 1',=
The equation is only approximate but if the values Sl=lO
and S2=1 are taken the ratio of ~olecular weights is 1.1:1 •
.(vi) Polyacrylamide gel isoelectricfocusing The
result of the iso-electric focusing demonstrated the
impurity of the enzyme eluted from the cellulose phosphate
column. The isoelectric point corresponds to that found
by other workers.
The various techniques applied here to differentiate
between different forms of the cyclic-AMP binding protein
and protein kinase could be employed jointly to purify
one or more forms of these proteins. This work represents
an extension of existing work. For exacple, a~onium
sulphate precipitation has been used in rllostpreparations
of the cyclic-AMP dependent protein kinase but only as
a concentration step and not as a fractionation. (see
Reimann et al.: 1911 and Yam~ura et al.: 1911).
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The results of these purification steps and the
binding studies carried out on the different preparations
strongly indicates that the binding of cyclic-lUll)to the
protein kinase is not just a simple one to one binding
equilibrium as has been generally assumed up till now.
CHAPTER 8
SOAIE PROPEhTIES OF THE CYCLIC-AMP BINDING PROTEIl'I
8.A. Introduction
The limiting sensitivity of the Brown assay for
cyclic-AMP is partially determined by the dissociation
constant for the binding of cyclic-AU~ to the protein
kinase (Ekins and Newman: 1970).
This chapter deals with some binding studies carried
out on various preparations and fractions of the cyclic-
AMP binding protein from the bovine adrenal cortex.
These studies were carried out because in the course of
this work it was found that some of the binding curves
were non-linear. Such binding studies are highly
relevant to the study of how the protein kinase functions
as a link in the second messenger role of cyclic-A11P.
Cyclic-etheno-AMP,. a fluorescent analogue of cyclic-
~4P, was prepared. Its use as a probe for investigating
the binding of cyclic-AMP to the protein kinase was
evaluated.
8.B. Materials and methods
All the materials and methods used in the work
presented in this chapter have been described elsewhere
in the thesis except for the preparation of cyclic-
ethenoAMP whieh is dealt with separately in section 8.F.a~
The assay used to measure cyclic-AMP binding was as
described for the assay of chapter 6 (6.B.b.), but the
ouA~entration of cyclic-AMP was varied.
The preparations of binding protein which were
used were the 5,000 x g supernatant (6.B.a.), amconium
sulphate fractions of the same (7.C.a.) and DEAE-
cellulose column fractions (7.C.c.).
8.C. Analysis of multicomponent binding curves
The binding curves constructed in this work were
based on the equilibrium relationship for one to one
binding in which there are no interactions between the
binding sites:
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[Protein kinaseJ.[cyclic-A}iIP]
[Protein kinase: cyclic-AMP complex]
Substituting E for the concentration of couplex, F for
the free cyclic-AMP concentration and P for the total
binding site concentration, the equation rearranges to
B = P - Kd'~'
A graph with B as the ordinate and E/F as the
abscissa will be a straight line if the binding species
is as described above.
A curved line with increasing gradient will result
if there are,more than one species of binding protein
present which have different dissociation constants for
the binding of cyclic-AI.1P. The curvature may also arise
from negative cooperativity or binding protein subunit
association/dissociation phenomena affecting either the
stOichiometry of the binding process or the dissociation
constant for the binding of cyclic-Ali~.
I If it is assumed that such curvature is due to the
presence of more than one bind'ing species, each of which
has a single non-interacting one to one binding site for
cyclic-ALlP, the curve can be analysed to give the
dissociation constants and
for the different species.
possible t~ do so with two
binding site concentration~
In practice,.it is only
binding species or t~ee if
the data is sufficiently accurate.
A graphical method of fitting curves to two binding
species was used (see appendix) which was adapted from
the work of Rosenthal (1967). Graphically the curve is
the radial sUm of the binding curves for the cocponent
species.
8'.D. Cyclic-AMP binding studies.
8.D.a. Cyclic-Ab~ binding curves for the 5.000 x g supernatant
The shape of the binding curve and the constants
derived from it were found to vary with the protein
concentration used (figure 8.1).
The binding curve (B against B/F) is best used f,!'
determining the dissociation constant of a binding
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process when the binding site concentration is of t~e
order of the dissociation constant or lower (Kd)l') and
the cyclic-AliIPconcentration varies froe approximately
Kd/2 to 4Kd• 'rhis is because the ElF ratio will be
most precisely det er-mi.ned under those coricitiona in
which both B and F can be accurately measured and this
is when the ratio is about unity. If P is much less than
Kd, the concentrations of B and F may be reduced to a
low level.difficult to determine accurately.
However, in the case of this cyclic-AlliPbinding
protein it appeared that the dilution of the protein
increased the dissociation constant. Also, given a
sufficiently high concentration of cyclic-AMP ()40ru.i) ,
the bindine curves displayed a curvature characteristic
of mixtures of binding proteins. This and the other
possible explanations for the curvature are discussed
more fully at the end of the chapter.
S.D.b. Cyclic-~~ binding to protein samples prepared by aumonium
SUlphate fractionation
The ammon ium sulphate fractions containing the
maj ority of the cyclic-Al.J>binding acti vity are shown
in figure 8.2 •. It appeared from these results that
I
the protein which precipitated between 20%· and 40/;
saturation had a slightly higher dissociation constant
than that which precipitated at higher or Lower- concen-
trations of ammonium sulphate.
The protein preCipitated at 15% saturation, and the
residue remaining after the removal of protein precip-
itating at 65/~ saturation, both had negligible binding
capacity for cyclic-Al~.
8.D.c. Binding of cyclic-AMP by protein fractions from a DEAE-
cellulose column
The dissociation constants for the binding of cyclic-
AMP by the protein fractions obtained from the DEAE-
cellulose column :n: (71. C.c.) were obtained.
Fractiqn A was not detected by the assay of the
coLuan fractions in which lOn1rIH3-cyclic-AI.IP was used,
but was detected in the assay in which lOOnI·:H~-CYCliC-
AMP was used. It was therefore considered that it was
-- -- --------
---- ---- ----- - -------------------------------------- ---'j
- --- --- _._---------_._---- -- - ._---------------
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a weaker binding protein for cyclic-~I.P than fraction
B which was detected in the presence of 10nM H3-cyclic-
AMP. The binding study carried out after the fI'c1ctions
haa been frozen and thawed gave the opposite result.
Fraction A was determined to have a dissociation constant
of 1.9nM and a binding site concentration of 8.9nl1.
Fraction B had a dissociation constant of 14rJ,I and a
binding site concentration of 7nM. The binding curves
are shown in figure 8.3. This re~ains an ~ocalous
result and no attempt Vias made to repeat it. The two
fractions were mixed with other protein fractions from
the same DEAE-cellulose column and assayed for binding:,·
activity. (8.E.c.). The binding of the f'r-ac t iorie A and
B diel not appear to be affected by ethanol at 5/~ concen-
tration in the cyclic-Al'llPassay (see 8'.E. b.). These
results are discussed at the end of the chapter.
8.E. Factors effecting the binding of cyclic-AlJP to its
binding protein.
8.E.a. The effect of cyclic-GMP on the binding of cyclic-AMP
The effect of cyclic-GI,ll'on the bincing of cyclic-
AMP by the 5,000 x g supernatant protein and the protein
from two ammonium sulphate fractionations and from DEAE-
cellulose column I was determined.
The effect of cyclic-GMPon the 5,000 x g supernatant,
and the 15 - 36% and 36 - 50% ammonium sulphate
fractions is shown in figure 8;.4. The cyclic-Al.lFbinding
assay was done in the presence and absence of lpM cyclic-
GMP (see section 6.B.b. for the assay).
Cyclic-GMP seems" at first sight, to be competitive
with cyclic-A1~ for the binding by the 5,000 x g super-
natant protein. However, the line veers from the
apparent intercept on the ordinate. It appears~ there-
fore that the dissociation constant and the number of
binding sites are both increased. A similar effect was
observed with the 15 - 36% aomonium sulphate precipitate.
In the absence of cyclic-GMP the 36 - 50% ammonium
sulphate precipitate had a biphasic binding curve. On
the addition of cyclic-GhIP the strongly bindirig component
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was not detected. These effects are discussed at the
end of the chapter.
The binding of H3-cyclic-AMP (lOnM) by the fractions
A to D from the DEAE-cellulose column I was deter~ined
with the following concentrations of cyclic-GMP present
10, 50, 250, and 500nM.
Increasing cyclic-GMP concentrations resulted in
decreasing amounts of cyclic-AIdP being bound. However,
the amount of cyclic-AMP bound in the presence of IOn!.!
cyclic- GMI) was consistently greater than with no cyclic-
GillP(figure 8.5).
'8. E.b. The effect of ethanol on the binding of cyclic-AlliP
The stock solutions of tritiated cyclic-~dP were
made up in 50~;o ethanol to reduce the tri tiurn exchange
between the cyclic-AMP and the solvent water. As these
solutions were not evaporated to dryness but were diluted
before use the tracer solutions contained a soall amount
(about 0.3% in the assay) of ethanol. Thereforesi:::lcethe
tracer used in the binding studies contained varying
amounts of ethanol the effect of ethanol on the binding
of cyclic-~i~ to the binding protein was exacined.
Two effects were observed. Firstly, with the 35-50%
ar~onium sulphate fraction the cyclic-AMP bound by the
protein was increased by ethanol concentrations up to
57Gby voluLle.(see figure 8.6). Secondly, at concentratione
above 5% ethanol the amount of cyclic-AMP bound decreases
as shown by binding curves for the 5,000 x g supernatant,
(figure 8.6).
8.E.c. The effect of DEAE-cellulose column fractions on
the binding of cyclic-AlJP
An anomalous result was obtained for the dissociation
constants of the two cyclic-AMP binding protein fractions
from the DEAE-cellulose column lI: (7.0.c. and 8.D.c.).
This led to an investigation ef whether the other column
fractions might contain effectors which might regulate
the cyclic-AMP binding activity of one or both binding
protein fractions.
Equal aliquots from each fraction were mixed wi"":"l.
the same volume of the two binding protein fractions.
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After leaving at oOe for one week the mixtures were
assayed for cyclic-AMP binding activity in the presence
of 10nM H3-cyclic-Al,lP. The results of this are shown
in figure 8. 7. There was a reduction of over 40;; of
the binding of cyclic-AMP by fraction B in t~.iepresence
of column fractions 28 to 40 relative to the cyclic-AlJP
bound by the other mixtures. Following the week during
which the mixtures were left the counts/minute bound
by the mixtures of fraction B with fractions out of the
range 20 to 48 was l880±150. This compares with the
counts/minute bound at the start of the we ek of 2900 by
the same amount of protein from fraction B.
The average counts/oinute bound by mixtures of
fraction A with other fractions was 3700±350. rhe
cyclic-AMP binding activity of the fraction A bi~ding
protein was not altered by mixing-with the fractions in
the range 28 to 40 but the counts/minute bound in all the
fmixtures was considerably less than the counts/minute
bound by fraction A itself (6620cpm).
These results are discussed at the end of the
chapter.
B·E.d. The effect of pH on the binding of cyclic-AMP
The effect of pH on the binding of cyclic-~JP was
tested by diluting the 5,000 x g supernatant in six
volumes of O.lM citrate-phosphate buffers at different
pH. The buffers each contained 8m11Itheophylline and
6mM 2-Llercaptoethanol. The various protein solutions
were centrifuged at 10,000 x g for 30 minutes to remove
insoluble protein. The supernatants were removed and
assayed for cyclic-~~ binding activity using the
procedure of section B.B.b. but at the pH of each
supernatant and not at pH 7.4. The precipitates were
resuspended in the dilution buffer (section 6.B.b.) and
assayed at pH 7.4 following the procedure of section
6.3.b• in order to deteruine the amount of active
binding protein that had been precipitated. The results
are shown in figure 81.8.
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81• F.a. Preparation of cyclic-ethenoAMP
Aqueous chloroacetaldehyde at pH 5.0 was re-
distilled. The fraction collected between '::'2°and 980C
was used for the reaction. Cyclic-A1lP (12rng) was
mixed with 20ml of the distilled chloroaceta11ehyde and
placed in a shaking water bath at 37°C for 24 hours.
The reaction contents were checked by tIc to estimate
the extent of the reaction. The tlc system is described
below. After 24 hours the reaction was almost complete
ana most of the aqueous chloroacetaldehyde was removed
by freeze drying overnight. The rel:lainingchloroacet-
aldehyde was recoved by adding 5ml of dis~illed water
and ether extracting twice. U.V. aba or-pt i.or; at ~225 to
350nm showed that the aqueous layer "laE free of chloro-
acetaldehyde and that the ether layer was free of
nucleotide. The volume of the solution was r€~uced by
rotary evaporation. '"
The cyclic-ethenoAMP was purified by applying the
solution to a 0.8 x 23cm DEAE-cellulose column equilib-
rated with 50mM ammonium acetate buffer at p:i 4.0. The
nucleotides were eluted with a convex gradient of the
same buffer increasing in concentration to 0.5hl. ~wo
major peaks of U.V. absorbing material were eluted
(figure 8 .9) • The U.V. spectrum of peak 1 showed a
single maximum at A276nm and a minimum at A248nm. The
second peak (2) also had a minimum at )..248nmbut hac two
maxima at )..266nmand ).275nm with shoulders at A25dnm
and A300~~. Peak 2 corresponds to the spectrum of etheno-
adenosine derivatives prepared by Secrist et al. (1972a)
(see figure 8.10). The compound in peak 2 also gave a
single fluorescent spot on cellulose tIc using iso-
butyric acid: NH40H: H20 (75: 1: 24 by volume) as used
by Secrist et al. (1972b).
8.F.b. The fluorescence of cyclic-ethenoAMP and the cyclic-~~
binding protein
The fluorescence spectra of the cyclic-ethenoAli1P
and a sample of protein from the DEAE-cellulose column
~ fraction B, are sho~n in figure 8.11. The protein
had an excitation maximum at A295nm and a fluorescence
Figure 8 .9
The purification of cyclic-ethenoN!P
using a DEAE-cellulose column
5ml crude cyclic-ethenoAMP was added to a 0.8 x 23cm
column of "DEAE-cellulose equilibrated with 50mM ammoni.um
acetate buffer pH 4.0. The sample VIaseluted by applying
a convex gradient of buffer to the column. The gradient
was made using a 100ml conical flask containing 100ml
of the 50ml'l1ammonium acetate and a 250ml beaker containing
about 110ml 0.5M ammonium acetate buffer pH 4.0. The
containers were linked by a siphon tube and the colunm
was fed from the conical flask. All the U.V. absorbing
material was eluted bp the first 100ml of buffer.
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Figure 8.10
The U.V. spectrum of cyclic-ethenoAMP
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Figure 8.11
Fluorescence snectra of cyclic-ethGnoAliIPand.the
cyclic-AMP binding protein from DEAE-cellulose
column ill
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maximum at A 350nm. This corresponds to the fluoreEcence
of tryptophan (excitation Amax287nm, fluorescence ~ax
348nm) rather than to the fluorescence of tyrosine
(excitation ~max275nm, fluorescence ~max303nm). Cyclic-
of 3l0nm and a fluor-ethenoA.MP had an excitation ).'maX
escence Amax of 420nm.
Changes in the polarity of the mediun do not affect
the fluorescence spectra:-:ofthe ethenoadenine derivatives.
except for a slight shift to shorter wavelengths (Secrist
et al.: 1972a). As the binding of cyclic-~JP to the
protein kinase is very firm it was thought that changes
in the polarisation of fluorescence would enable a study
of the binding process to be carried out.
The polarisation (p) of fluorescence is given by
the following equation:
Vv - K.Hvp = -----Vv + K.Hv
where the symbols V and H refer to the settings of the
polarising filter placed immediately before the sample
in the excitation light and the symbols v and h refer to
the settings of the pols.rising filter placed between
the saople and the analysing monochromator in the Farand
fluorometer. In the settings V and v the electrical
vector of the polarised light is vertical to the plane
of incidence and observation and similarly H and h refer
to the settings in which this vector is horizontal to
the same plane. K is a correction factor for the non-
ideal transmission of polarised light through the
analysing monochromator. It is given by:
K = Hv/Hh.
The fluorescence spectrum of the protein solution
partially overlapped that of the cyclic-ethenoAhlP.
Therefore a wavelength was chosen at which the contrib-
ution made by the protein fluorescence to the total
fluorescence was minimised. (table 8.1).
S.F.c. The binding of cyclic-ethenoA1~ to the binding protein
The protein used for this work was the same as that
used in the fluorescence measurements. (fraction B froe
DEAE-cellulose column ]I). An aliquot of lOOpl of the
binding protein diluted to 300fl in the presence of
-s8-
100r~ H3_CYClic-~~ bound 10.5pmol of cyclic-AMP.
Therefore the concentration of binding sites (assuming
that they were saturated with cyclic-AMP) is about
rooea.
The relative fluorescence and polarisation of
fluorescence of the binding protein, a solutior. of 130~1
cyclic-ethenoAlJP and a mixture of the two were measured.
The spectral data for the solution of cyclic-etheno~~
were obtained by adding l}Jl of a 0.38mM solution of
cyclic-etheno.Al~1Pto 3.Oml of clean distilled water
using a l)Jl capillary tube (Ir1icrocaps). The cyclic-
ethenoAU~ was added to the protein solution in the same
way. The results are also shown in table 8.1
Table 8.1
a) The relative fluorescence intensity of cyclic-etheno-
AMP and the binding protein solution at various wave-
lengths.
Excitation Fluorescence Cyclic- Frotein
wavelength wavelength ethenoAi,IP kinase
. nm nn If (reI p If (reI p .
310 415 16.5 '-0.005 1.94 0.319
315 425 14.6 1.20
320 440 11.2 0.009 0.84 0.478
325 450 8.0 0.75
b) The relative fluorescence and polarisation of
cyclic-ethenoAMP and the binding protein solution.
(Excitation ~320nm, fluorescence A440nm)
Solution Time after If (rel) p
mixing
l30nM cyclic-ethenoA1~ - 0.020 0.036
Binding protein - 0.138 0.470
" " + c- AMP 3 min 0.131 0.471
" n 11 6 " 0.127 0.'480
II " " 16 h 0.126 0.494
It was clear that the protein fluorescence was too
high and masked the cyclic-etheno~dP fluorescence, there-
fore further purification of the binding protein was
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required. However, there was a 5% increase in polar-
isation over the period of 16 hours, though most of this
change occurred relatively quickly (2% in 6 minutes).
Sanborn et al. (1973) have shown that the rate of
association between cyclic-AMP and endometrial protein
kinase is high and that a significant degree of binding
occurs in a few minutes.
".' .
8.G. Discussion
It was Boticed that the data obtained from binding
curves for the concentration of binding sites and the
dissociation constant for the binding of cyc1ic-A1~ to
the protein kinase varied with the concentration of the
protein and the cyclic-AMP used. This is a fact that
has been noted in passing by other workers (iJunderwald
et al.: 1974) but which is of vital importance to an
understanding of how the protein kinases function in
response to cyclic-AMP.-
As shown in figure 8.1 it is possible to get curved
or linear binding plots for a 5,000 x g supernatant
preparation depending on the dilution of the protein and
the concentration range for the cyclic-AMP.
There are a number of possible reasons for curved
binding plots.
(i) Multiple binding species: by which is meant the
pr.esence of two or more unrelated proteins capable of
binding cyclic-AMP.
(ii) ASSOCiation/dissociation of binding proteins: by
which is meant that the protein kinase RC complex is
able to dimerise to give R2C2 and perhaps higher
aggregates or to dissociate to R and C spontaneously.
It is assumed under this heading that the associated or
dissociated forms of the protein kinase have different
binding constants from the RC complex.
(iii) Allosteric regulation: which is taken to include
co-operative binding and regulation by effectors.
The data from the binding studies on the 5,000 x g
supernatant, the ammonium sulphate fractions and the
DEAE-cellulose column fractions is tabulated below (table
8.2).
_----- -- --_
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Table 8.2
Dissociation constants obtained for various preparations
of the cyclic-Amp binding protein (nM)
5,OOOg Ammonium sulphate fractions DEAE-cellulose
super- % saturation fractions
natant 0 10 20 30 40 50 60 A B
- 0.7 -d3
- 0.7 -d3
- 0.7 -d3
0.8 d1 - 0.8 -
1.5 d1
1.9. .- 3.0 -
- 3.4 d2-
3.9 d1
- 4.1 -- 5.1 d2-
7.0 d1
- 9.7 d2-- 10.0 -.
14
15.5 c
- 21 d3-
- 21 d3-
'~-~'-/':" .",~ ~-'.'~:~12·.', " . .. "21"d)"- - -._' ~ 1"~' - -, :: .... '.' ..
- 28 -- 30 c -
- 44 -
- 44 c -
67 dl
The data was obtained as described in the text:
c indicates results with cyclic-GMP present, d1, d2 .••.
are data for different dilutions of fractions 1,2 •..•
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The dissociation constants fall broadly into three
categories.
(a) Dissociation constants of the order K < 2 which are
not changed by dilution but are sensitive to cyclic-GLIF.
The preparations giving binding constants of this type
are the 5,000 x g supernatant when undiluted, the 36 - 50
percent saturation ammonium sulphate fraction and the
DEAE-cellulose fraction A (see sections 6.B.a., 7.C.a.
and 7.c. c. ]I respectively for the preparations and
figures 8.1, 8.2, 8.3 and 8.4 respectively for the
results of the binding studies).
(b) Dissociation constants of the order 2 < K < 10
which are dependent on the dilution of the binding
protein and are also affected by cyclic-GMP. The
preparations giving this type of dissociation constant
are the 5,000 x g supernatant when undiluted if high
concentrations of cyclic-AMP are used to determine the
constant, and diluted ff low concentrations ef cyclic-
AMP are used in the binding study. !he ammonium SUlphate
fractions precipitating between 0 and 36% saturation
also fall into this category. The results may be seen
in the sections mentioned above.
(c) Dissociation constants K> 10. The dissociation
constants in the range were Observed with the diluted
5,000 x g supernatant with high concentrations of cyclic-
AMP and as a component of the 36 - 50% ammonium sulphate
fraction. Similar high dissociation constants were
observed for the 20 - 40% ammonium sulphate fraction
and the samples in category (b) which were examined for
the binding of cyclic-AMP in.the presence of cyclic-GMP.
These results may arise from a protein subunit
association/dissociation phenomenan. Miyamoto et al.
(1971) have shown by sucrose density gradient centrifu-
gation that there are three interconvertible protein
kinase activities in a preparation from bovine brain.
They have molecular weights of 140,000, 80,000 and
40,000. Only the larger two are cyclic-AMP dependent
and they are also activated by histone. This gave rise
to the postulate that there was an R2C2 complex, where
-92-
R refers to the regulatory subunit of the protein kinase,
which was capable of dissociating to 2RC. This may
have been occurring here although the molecular weight
studies necessary to confirm it were not carried out.
However,this phenomenan itself is insufficient to account
for all the result~'for example the dilution curve
(figure 7.7).
The sole sucrose density gradient work was done
with the binding protein fractions from DEAE-cellulose
column I (section 8.C.e., figure 8.9). A bind~g
activity at high molecular weight appeared as a shoulder
on the ma~ peak of binding activity from fraction At
which is thought to be the protein kinase holoenzyme.
Another possible explanation for the anomalous
binding of cyclic-AMP by the D~AE-cellulose fractions
(section 7.C.c. II and 8.D.c.), though it does.not exclude
the protein subunit association/dissociation hypothesis,
is that there is an effector molecule present in the
5,000 x g supernatant. Walsh et al. (197l) demonstrated
the presence of a heat stable protein which inhibited
skelet~l muscle protein kinase and increased the cyclic-
AMP binding activity. In section 9.E.c. it was shown
that a fraction from the DEAE-cellulose column ~ separate
from the cyclic-AMP binding fractions, was capable of
reducing the cyclic-AMP bound by fraction B. The
protein applied to the column was a 30 - 65~~ammonium
sulphate precipitate which had been extensively dialysed
against 20mM Tris.Hel buffer pH 7.3 containing 6mM
2-mercaptoethanol. The effector was therefore not
dialysable but no further characterisation was carried
out.
Either of these effects may be the cause of the
curvature of the binding plots observed for the 5,000 x g
supernatant and the 36 - 50% ammonium sulphate fraction.
However, this does not rule out the possibility of
multiple binding species. Indeed there is some evidence
in favour of them. The two protein fractions from the
DEAE-cellulose column Rwhich had different 4issocia~ion
constants for the binding of cyclic-AMP and which
responded differently .hen they were mixed with the
other column fractions may be interpreted in this way_
The different binding proteins would not be expected to
show the same response on being mixed with an inhibitor
or other effector.
Cyclic-etheno~JP was prepared because of its pot-
ential as a f~uorescent probe in the study of the protein
kinase activation by the binding of cyclic-AMP. The
results showed that although the binding of the probe to
the regulatory subunit of the prot"ein kinase did not
produce a significant change in the wavelength of the
fluorescence and excitation spectra there was a change
inth9'~P91arisation of the fluorescence. However, e,a
further purification of the enzyme was required for more
detailed studies.
The fluorescence technique would be a powerfUl one
when applied to the determination of kinetic constants
for the activation of the protein kinase by cyclic-AMP.
No other existing assay is really adequate for kinetic
.s.~1.ld.j.esof. ihi$ .prooese ..(Sanborn et al.· 19.13).
CHAPTER 9
DISCUSSION
. , ...' ~ /'
9.A. The work presented in this thesis arose out of an
interest in the controls necessary for the direction of
metabolic reactions into pathways of synthesis and
degradation which are essential for life. At first
particular interest was centred upon the purine pathways
which provide an intricate network of reactions Fequiring
a high degree of control. 'Nhenthe work on the purines
drew to a close.interest was directed towards the control
exercised by cyclic-AMP on metabolism, in particular from
the aspect of the activation of the protein kinase by
cyclic-AMP.
9.B• The investigation into purine flux was intended to
shed light on the factors controlling the adenine
metabolism of the red cell and to see under what
conditions the catabolism of ATP took place.
Approaches were made at two levels: firstly, to
assay enzyme activities in the red cell and secondly,
to study the fluxes in the pathw81 using radioisotopic
tracers.
".Vorkat the first level was conducted on AMP deaminase,
an enzyme critically placed in the purine pathway. It
is involved in the conversion of ATP into GTP and the
catabolism of ATP. It is found .tobe contrelled by a
number of inhibitors, the most important of which is
2,3-DPG. The enzyme w~s partially purified and assayed
spectrophotometrically.
'Norkat the second level was conducted on the metab-
olism of purine bases by using radio-isotopic tracers.
The metabolic products were separated by thin layer
chromatography and the radio-activity of the products
was determined by liquid scintillation counting. The
radio-activity of any product is a function of the flux
in the pathway and of the isotopic dilution of its
precursors. The results obtained agreed qualitatively
;>i,~",:' :.tt:t{"those"of other workers but'"tlieteChni'cal-problems
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prevented the refinement of the technique necessary for
quantitative results. A brief study of the transport of
purine bases into the red cell showed that their influx
into the cell was diffusion limited. The rate was not
affected by adrenalin, a compound known to alter the
properties of the red cell's membrane.
A hypothesis coupling the action of AMP deaminase
with haemoglobin was formed. They are linked by the
common effector 2,3-DPG. However, there does not appear
to be a straightforward relationship between the
oxygenation of the cell and A1dP deaminase activity
(section 1.E.). An alternative role for AMP deaminase
in addition to its accepted role in the interconversion
pathway for purine nucleotides may be in the ce11 aging
process. This hypothesis can be stated as follows:
the red cell requires ATP for the maintenance of its osmotic
balance and cell shape. Gomperts (1969) estimated that
the red cell utiltses over 50~ of its ATP supply for
this purpose. ~e reaction of AMP kinase is near equil-
ibrium because of its high activity in red cells so the
following equation applies:
Keq - ADP Mg.ADP / AMP Kg.Am'.
The ATP is formed from ADP by glycolysis and this
aormally ensures a high concentration of ATP
and a low concentration of AMP in the cell. It has
been observed that in old cells the rate of glycolysis
declines. The thermal denaturation of hexokinase may
be largely responsible for this (Gomperts: 1969). As
a result the 2,3-DPG from the pool within the red cell
is used as an energy source and its level declines (Haidas
et al.: 1971). The decline in the level of 2,3-DPG
makes haemoglobin a less efficient oxygen donor and also
releases AMP deaminase inhibition. The net result may
be a self destructive mechanism for old red cells which
have inefficient oxygen carryingeapacity.
This hypothesis should be tested further by
separation of the cells according to their age and
examination of the relevant enzyme activities and
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fluxes within the cells. Since red cells have densities
which vary according to their age, isopycnic centrifug-
ation can be used to accomplish a separation of cells
of different ages. (Danon and Marikovsky: 1964).
9.0. During the preliminary studies of the binding
protein for the assay of cyclic-Al~ it was noticed that
binding curves obtained for the protein varied from one
preparation to the next. This observation led to the
idea that binding equilibrium for the activation of the
protein kinase by c~clic-AMP may be more cocplicated than
is commonly assumed. The occurrence of non-linear
binding curves has also been reported in passing by
Gill and Garren (1969) and Vlunderwald et al. (1974).
In this discussion some of the possible causes of such
curvature are considered. The derivation of the equations
given in the discussion are to be found in the appendix.
Firstly, the different types of equilibria which have
been considered are listed together with the equilibrium
equations. The properties of each of the equations are
discussed here though the detailed treatment is to be
found in the appendix. SecondlY,the theoretical
treatment of the equations is compared with the experi-
mental results.
9.D. Binding equilibria.
1; Single site binding protein:
Kl
R + c-AMP = R.c-AlJP
The equilibrium equation is of the form:
B = P - Xl. (B/F).
A plot of 'boundf against 'bound/freer is a straight
line with gradient Kl and 'bound' intercept P, the
concentration of binding sites.
2. ~!!!~!_~!_!~P!_~_~!~~!~~p~~!!~!.
Ki
R. + c-AMP = R .• c-AldP
l. l.
The equilibrium equation is of the form:
B = ~Bi - Lti - 4Ki.Bi/P •
• Bound and free refer to ooncentrations of ligand •
. .
This equation may also be expressed in radial
co-ordinates (r, e), where B= r.sine and B/F= r.cose:
R }' ... I P.=~r1 = 1
~ K .•cose - sine.
• J.
J,
It can be seen more clearly from this equation that
R is the radial sum of the lines
r. = P./(K ..cose - sine).
1. 1: 1.
This means that the shape of the curve depends on
the dissociation constants ~i) for the binding
proteins constituting the mixture and their relative
concentration. Dilution of the mixture of binding
proteins will not affect this.
3. 2!~1~_!~!~_~~~~~~_E~!~!~_!h!!a_~!~~2£!!!~~_2~
£l£!!£=~_E~~~~~· K
RC + c-AldP~R.c-AMP + C
The equilibrium equation is of the form:
2B = P - K3.(B IF).
This equation may be rearranged to give:
Be P
1 + X3• (B/F) •
So a plot of B against B2/F will be a straight line,
but a plot of B against B/F will be a hyperbola. in
which the B/Faxis is an asymptote.
4. ~~~1~_~!!!_E!~~!~~_Er2!~!~~!!h_~~E~!!_~!~!~~!!!2~
E£~E~~~~~!_~~~h~_E!~~!~~_~!_Sl21!£=!!E.
.....' RCe It +.0
R + c-AMPe,R. c-AMP
(RC + c-AMP = R.c-AMP + C
X.,= K•./K")
The equilibrium equation is of the form:
P
B D 1 + ~.(B/F) - K••(B/F)
KI
If K,» K. then the equation is approximately of
the form:
B - P - x..•(B/F)
-98-
and the plot of B against B/F is a straight line.
However, if K.' Kw. then the equation cannot be
simplified. The plot of B,'against B/p gives a
curve. The B/p intercept of this curve varies
according to the concentration of the protein. If
P» K, then the intercept is proportional to IF and
if P«K. then the intercept is proportional to P.
So the apparent binding data obtained from the plot
will vary with protein concentration.
5. ~i~~E!£_Er21~~_~h!£h_~!~~2£!!1~!_12_E~2~~£~_!~2
1lE!_J_~~~!~~_E~2~~~~~
R202 = 2RCI\.RC + c-AMP = R.c-AMP + C
The equilibrium equation for this is of the form:
B = P - K,. .(B2/F) {l + !a. (B2/F»
K.
The equation cannot be reduced to a form in which
B is a function of B/p only. If K,»~ then the
equation is of the form found in 3.
6. Ui!!r!£_E~2!!!2_~h!£h_~!~~2£!!!!~_!~_~2~~£!_!!2
!lE!_!_2!a~~_E~21X~!~
R2C2 = 2RCx,
RC == R + CKt.R + c~AMP = R.c-AMP
The variables in the equilibrium equation cannot
be separated in this case, but in the limiting case
when K, is infinite the equation reverts to type 4.
As shown in the appendix the shape of the curve can
be dependent on the protein concentration.
Of these six examples of binding equilibria only the
first two give binding curves of the form B against B/p
which are not dependent on the protein concentration.
9.E.
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This theoretical analysis of the possible binding
equilibria and the binding curves which arise from them
can be applied to the experimental results. Firstly,
none of the binding curves (shown in chapter 9) of
'bound' against 'bound/free' ligand are hyperbolic.
They all have clear intercepts with the 'bound/free'
axis. This rules out the form of binding in section
9.D. types 3 and 5. The first of these is of the form
RC + cAMP = R.cAMP + C
which is commonly assumed to be the equilibrium
governing the activation of the protein kinase.
Secondly, the theoretical analysis shows that
changes in the binding curve brought about by using
different concentrations of the binding protein are a
criterion for distinguishing different binding equilibria.
This is exemplified by reference to the binding curves
for two protein fractions prepared by ammonium sulphate
preCipitation from the bovine adrenal cortex 5,000 x g
supernatant (see figure 8.2). The protein fraction
preCipitating between 15 and 36% ammonium sulphate
saturation gave a binding curve which waa approximately
linear and the slope of which increased with protein
concentration. (apparent dissociation constant decreases).
The ratio between the protein concentration (binding
sites) as given by the 'bound' intercept and the 'bound/
free' intercept .for the three dilutions of binding
protein used was 9.9:1, 5.8:1 and 3.5:1 respectively.
This ratio.is not constant. However, the ratio between
the square root of the binding site concentration and
the 'bound/free' intercept for each of the three dilution.
was 2.5:1, 2.0:1 and 1.8:1 respectively. These ratios
are more nearly constant and are in accord with the
predicted behaviour for the binding of cyclic-AMP by
a protein kinase which dissociates into the catalytic
and regulatory subunits before binding cyclic-AMP (type
4 binding protein: see 9.D. and the appendix). The
condition required by the theor,y for this to be true is
that both the protein binding site concentration and
x.. are greater thaD It,. (X, and X. are defined in 9.D.).
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Sanborn et al. (1973) proposed that uterine protein
kinase bound cyclic-AMP in a similar manner.
The second fraction precipitated by ammonium
sulphate between 36 and 50~ saturation gave curved
binding plots. The shape of these plots did not vary
on dilution and was consistent with them being the
radial sum of two straight lines. This behaviour is
predicted for a mixture of single site binding proteins
which have no subunit dissociation (type 1: 9.D. and
appendix) •
9.P. The 5,000 x g supernatant of the bovine adrenal
cortex was fractionated by a number of methods. Binding
studies were carried out on the different fractions
According to the theoretical criteria shown in the
appendix the binding species in some of the fractions
were identified. The binding studies showed that the
fractionation procedure had to be carefully controlled
in order to obtain consistent results.
The result of the binding studies carried out on the
protein fractions obtained by ammonium sulphate fraction-
ation indicates that this technique alone is sufficient
for separating the protein kinase from the regulatory
subunit. The protein kinase was identified by the
binding equilibrium which it exhibited. It is usually
taken that cyclic-AMP initiates the dissociation of the
protein kinase into the regulatory and active catalytiC
subunits. However, the results of this binding study
imply that there is a significant dissociation of the
protein kinase into its subunits prior_to the binding
of cyclic-AllP.
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Abbreviation
a
A
ade
ABBREVIATIONS
Meaning
atto (10-18)
absorbance, loglO(IoII)
adenine
adenosine deaminase
adenosine kinase
adenosine aminohydrolase (EC 3.5.4.4.)
ATP: adenosine phosphotransferase
(EC 2.7.1.20.)
ado
ADP
AMP
AMP deaminase
AID? kinase
-AMP-S
APRT
ATP
B
B.S.A.
c
c.a.
cpm
adenosine
" -5'-diphosphate
" -5'-monophosphate
AlUPaminohydrolase (EC 3.5.4.6.)
ATP: AMP phosphotransferase (EC 2.7.4.3.)
N6_succinyladenosine-5'-monophosphate
AMP:PP. phosphoribosyltransferase€(EC 2.4.2.7.)
1
adenosine-5'-triphosphate
concentration (or cpm) of bound fraction in an
~~uilibrium) binding process.
bovine serum albumin (fraction V unless specified
as otherwise)
concentration
circa
cyclic adenoBine-3',5'-monopho~phate
Curie
Radioimmunoassay nomenclature of Hales and Randle
(1963). Ratio between 'zero' and'sample' count
rate.
count rate, counts per minute.
cyclic-AMP as cAMP
cyclic-ethenoAMP 3H-Imidazo ~,l~~purine, 3-(3,5-0-
phosphinico~-D-ribofuranosyl) Chemical Abstracts
nomenclature
d
D
DEAE-cellulose
dila
DNA
2,3-DPG
optical depth
toluene excimer
diethylaminoethyl-cellulose
dilution
deoxyribonucleic acid
2,3-diphosphoglyceric acid
-109-
EDTA
2-EE
equm
Es
F
e
G
GDP
gln
glu
Gli:P
GMP kinase
G11P reductase
-110-
ethylenediaminetetraacetic acid
2-ethoxyethanol
equilibrium
external standard reading for the Packard series
2450 liquid scintillation counter
concentration (or cpm) of free ligand fraction
in an (equilibrium) binding process
gram, acceleration due to gravity
Gibb's free energy
guanosine-5'-diphosphate
glutamine
glutamic acid
guanosine-5'-monophosphate
ATP: GMP phosphotransferase (EC 2.7.4.8.)
reduced NADP: GMP oxidoreductase (deaminating)
(EC 1.6.6.8.)
GMP synthetase XII1P:ammonia ligase (AMP)
GTP guanosine-5'-triphosphate
gua
guanase
guo
h
Hb
HGPRT
hyp
Io
Irel
ll1P
ino
K,k
K.
l:
Km
1
m
M
min
mol
(Ee 6.3.4.1.)
guanine
guanine arainohydrolase
guanosine
hour, Planck's constant
haemoglobin
I~~: PPi phosphoribosyltransferase
(EC 2.4.2.8.)
hypoxanthine
intensity of incident light, or radiation
relative intensity (of fluorescence)
inosine-5'-monophosphate
inosine
equilibrium constant, rate constant
inhibitor constant
Michaelis constant
litre
milli, 10-3
molar
minute
gram molecule
n
NAD+
NADH
NA.D?+
I'~ADPH
51-nucleotidase
p
PEl-cellulose
pH
Pi
PNPlase
POPOP
PPi
FPO
PRPP
pyr
pyr-P
r
R
S.D.
S.D.S.
S.G.
T
TCA
tIc
u.v.
v
Vmax
xan
xanthine oxidase
xao
XillP
-111-
neutrino, nano, 10-9
nicotinamide adenine dinucleotide
reduced NAD+
nicotinamide adenine dinucleotide phosphate
reduced NAJ)P+
51-ribonucleotide phosphohydro1ase
(EC 3.1.3.5.)
polarisation (degree of)
po1yethyeneimine-cellulose
-loglO(hydrogen ion concentration)
orthophosphate
purine nucleoside: Pi ribosyl transferase
(EC 2.4.2.1.)
1,4-bis-(2-(5-phenyloxazo1yl»-benzene
pyrophosphate
2,5-diphenyloxazole
~-D-ribose-l-pyrophosphate-5-phosphate
pyridoxal
pyridoxal phosphate
fraction of tracer bound to a specific binding
protein
gas constant, response parameter (nomenclature
of Ekins et al. 1968)
standard deviation
sodium dodecyl sulphate
specific gravity'
temperature (Kelvin), toluene
trichloroacetic acid
thin layer chromatography
ultra violet
rate (of reaction)
maxiLlum rate for an enzyme catalysed reaction
xanthine
xanthine: 02 oxidoreductase
(EC 1.2.3.2.)
xanthosine
II -5'-monophosphate
)...fluor
Pf
(3 -particle
partial differential
change (in)
extinctim·coefficient,
. -6m~cro, 10
frequency
wavelength
II at maximum absorption
at which excitation of fluorescence"
11
is measured
at which fluorescence is neasured
fluorescence quantum yield
infinity
A theoretical discussion relating to binding curves
In this appendix the equilibria governing the
shape of binding curves are considered. The same
symbols will be used throughout the discussion.
B bound fraction concentration (of cyclic-AMP)
)free fraction It (.. "
P binding sites It
Pi
K equilibrium or dissociation constant
RC protein kinase
R " II regulatory subunit
C " " catalytic "
r concentration of R
c " " C
1. ~g1~!a_~!!~_!_~!~~!_~!a~!~~_~!!!_~-2_~2_~!!!!£!!~~
sUbunits.---------
Equilibrium: XlR + c-AMP = R.c-AMP
Equilibrium relationship:
TT (p - B).P
A.l = .
B
This equation rearranges simply to give:
(ii)
B = P - IS.., (B/p) ._ ( iii)
The plot of bound against bound/free (B against B/F) is
a straight line with gradient -Xl and intercept on the
B axis of P.
2. ~!~~~!_2f_~~E!_!_E!~~!~~_E~2!!!~~~
K.
Equilibrium: Ri + c-AMP J. R:rc-AMP (av)
The same equation applies for all components (i) of the
mixture.
Equilibrium relationship:
~ _ (Pi :V.F (v)
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3.
-114-
which rearranges to give the relationship:
B. = P. - K.• (B./F). (vi)
l. l. l. l.
Again the same equation holds for all the components of
the ~ixture. The total bound fraction will sicply be
the sum of the different components' bound fractions.
B. Bi (vii)
The result of this sumoation is not easy to see. However,
if the equations for the different components (vi) are
rewritten in the perpendicular form for radial co-
ordinates, we have:
Pi = (viii)
K .• ccae - sine
l.
These equations summed over all the components clearly
gives the radial sum of the straight lines which
represent the c'ontribution of each component of the
mixture of binding proteins to the total cyclic-AMP bound.
~ LP.fi. = p. = . l.l. Ki.cos9 - sine. (ix)
Some examples of such curves are shown in figure A.l
E~2!!!~_~~1h_!_~!~~!!_£!~~!~~_!!1!_~~1h_~~E~~!
~~~~2~~~!~2~_2~_E~~~!~_2ir.~l~!~~=~E~
Equilibrium: RC + c.,.AMP:;R. c-AMP + C
Equilibrium relationship:
K fp-B).F3 -= 2B
This equation rearranges to give:
(x)
(xi)
B = P - K3.(B2tr).
A plot of B against B2/F is a straight line. The
equation may be rearranged to give a relationship
between B and B/p:
(xii)
P
B = ------------- (xiii)
(1 + K3• (B/P».
This is the equation of a hyperbola. The intercept on
the B axis is P. Differentiating (xiii) with respect
to Blp we get:
(xiv)
Figure A.l
Theoretical Binding Curves for,a Mixture of Type ~
Binding Proteins
The figure shows how curved or almost linear
binding plots may arise from a mixture of
binding proteins. The effe.9~__of _slilutionon
these curves is also shown.
a) A;::.mixtureof two proteins
r-
giving an almo~t_line~
binding curve...
rO
§
o,c
•
\
\
\
\
\
\
\
- - \_ -r - - - ....
b) A mixture of two proteins
giving a curved binding
plot •
'bound/free' ligand
c) Change in curve a) on 1 in 2 d) Change _in curve b) on
dilution~twice. 1 in 2 dilution twice.
Arbitrary units
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The gradient of the line at the point of interception
on the B axis is therefore -P.K3. The initialgradient of the' line is dependent on the protein
concentration. The B/p axis is an asymptote of the
hyperbol~. Examples of this type of curve are shown
in figure A.2.
The two equilibrium relationships are:
K, = (r -B).c
(p - r)
_.._(r_-_B~~Ke. : -
B
r : 'K... (B/p) + B
(xvii)
(xviii)
Prom (xviii) (xix)
and substituting for r in (xvii) and putting cc': r
we get:
K,.(P - K.•• B - B) : K.•• B.(K...B + B)F J F
Rearranging (xx) becomes:
-B. (K, + Ke•• B) = K., .B. (K, + Ke•• B) - K,.F
F t F
(xx)
(xxi)
Dividing (xxi) by -(KI + Ke,. B) we get:
J
p .
B: -~~ - Ke•• B
1 + '.B ,14'
Now if K.,«K, then the equation will be approximately
of the form seen for equation (iii), and the plot of
B against Blp will be very ne~rly a straight line.
If KI.) K, then this simplification does not apply,
however, we can find the intercepts of the curve with
the axes and differentiate to find the gradient of the
(xxii.)
line.
The intercept on the B axis is clearly F.
Putting B = 0 and rearranging we can get a quadratic
equation the positive root of which is the intercept
on the B/Faxis, (B/F)o.
Figure A.2
Theoretical Binding Curves for TYE!_3~~ding Proteins
B = P
(1 + K3. (B/FJ).
~ --
,
\
..
re
§
o
.0..
,
\
\
\
\
\
\
\
,
\
\
\
\
\
\
\
\
\
\
\
\
\
,,,
\
\
\
\ \
\, \ \, \,, \,,\\,\,,
Arbitrary units 'bound/free' ligand
The three curves represent binding plots for three serial
dilutions of a type 3 binding protein. The dotted lines
which meet on the abscissa show the intial gradient of
the lines to be proportional to the concentration of
binding sites.--. ,..,-
'Ii
5.
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(xxiii)'
The positive root of this equation is
K, • ./1 + 4FjK, _ K,(B/F)O = --L.~ __
2l(..
(xxiv)
If F» K, then Ii + 41'/K, is approximately 2. ff;K:·
and the intercept (B/F~is proportional to /p .
.11' 4P«K, then II + 4IjK, is approximately (1 + 2P/K.)
by the binomial expansion and the intercept (B/F~is
proportional to P.
Differentiating (xxii) with respect to (B/F) we get:
dB
d(B/F)
- K.. (xxv)
As (B/P) increases the gradient increases and approaches
the value of ~~~ The gradient of this line is always
an overestimate of Kt••
The gradient of the line at the point of interception
with the B axis is given by:
dB = -l(. •• (1 + P/K, )d(B/F)
(xxvi)
The gradient here therefore depends on the protein
concentration. The change of gradient at this point
with protein concentration is greater when P is large
in"comparison with K~.
Some examples of these results are found in figure A.3.
~!e~r!£_E~212~~_!~~!~!_~~~~2£!!!~~~_!2_~~Y!_!~E!_J
E~~~!U~_Er2~~~~~~
The two
K,
R2C2 = 2RCK..
Ra + c-AMP = R. c-AMP + C
equilibrium relationships
__~P, _ B)2K, (xxix)
Equilibria: (xxvii)
(xxviii)
are:
(xxx)
Figure A.3
(i)
Theoretical Binding Curves For Type 4 Binding Proteins
Variation in curve with protein concentration.
P
B = - K". (B/F)K..
1+ -(ElF)
K,
K, = K..
P varies from 6.4K, to O.4K,
Arbitrary_units
.
'd
§
o
..0-
'bound/free' ligand
The figure shows the variation of the binding
curve with the concentration of binding sites
and with the variation of binding constants.
Figure A- 3
(ii)
Theoretical Binding Curves for Type 4 Binding Proteins
Variation of curve with t~e~on~tant K..
c)
K, varies from 8K" to O.25K.t
P = 6.4Ku.
Arbitrary units
.
re
§
o
,0
•
a)
b)
'bound/free' ligand
Values of K,: a) 8, b) 4, c) 2, d) 1, e) i and f) i x ~.
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From (xxx) it can be seen that:
B2
P, = K,'F + B
)
(xxxi)
K•• (p" -
in (xxix) we get:
B2 • B2 2
Kw'·T - B) = (Ku ·r) (xxxii)
substituting for P,
Dividing both sides by K, and rearranging:
B2 KtL B2
B = F" - K". T· (1 + re·T)· (xxxiii)
The equation (xxxiii) cannot be treated in the form
B as a function of B/F,without becoming obscure because
of its complexity. However, it can be seen that (xxxiii)
will revert to the form of (xii) if K,» K.,.
The relationship between B and B/p is:
(xxxiv)
(
( K.•• B/P + 1). (
B =
As with equation (xxxiii) this one simplifies when K,» ~.
to give (xiii) by expanding the square root ter~
binomially and ignoring second order and higher terms.
6. ~i~~~!£_E~2~~!~_~i~~2~_~!~~2£!~~!~~_!2_~!Y~_!~E~_~
·§i~~!!!~LE~2~!!~~!.K
Equilibria: R2C2 ~ 2RC (xxxv)K..RO = R + 0 (xxxvi) .K,...
R + c-AMP = R. c-AMF (xxxvt i.)
Equilibrium equations: 2
K, = ip.....- r)
P,,- P,
K.. = r. (r - B)
p.- r
K..: = __(r -....;:B.LJ:
(xxxviii)
(xxxix)
(xl)
B
From (xl) r = K.... B/F + B. (xli)
Substituting for r in (xxxix) and rearranging
P, = CK.•• B + B). (!m. B + 1)
P X; if
(xlii)
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Substituting for r and P, in (xxxviii) using (xli and xlii)
we get:
(!u..~ (K".B B»2Kw, F· F +
K •. = -------------
- Ptt - (KIt·B + B). (t·J + 1 )
The vari~bles B and B/F or B and B2/F cannot be separated
(xliii)
simply in this equation with out resorting to taking
roots as in 5. The limiting case when K, approaches
infinity will occur if the denominator in (xliii)
approaches zero. If the denominator is equated with
zero it can be arranged to give equation~ii).
The equation for B in terms of B/F is:
3 3_ 2K!lI. B _ 1Lu..B_1
K • 2.F3 K F
B. = ._--~------------~~~~-~~~-----~-----
(xliv)
~his equation reduces to (xxii) if the square root term
is expanded binomially and second order and higher terms
are ignored. This procedure is valid if K, is very
large or if p. is very small.
